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1. Introduction 
I.a. Stress 
Stress is a common experience of daily life and all organisms have developed mechanisms to 
cope with it. Sustained stress can have numerous pathophysiological effects such as 
activation of neuro-endocrine [limbic-hypothalamic-pituitary adrenal system] (Bonfiglio et 
al., 2011) and hormonal (corticosterone release) functions (Fuchs & Flugge, 1998). Sustained 
and persistent stressful conditions can precipitate anxiety and affective disorders such as 
depression, which further leads to the excessive production of free radicals and oxidative 
burden (Maes et al., 2011).  
Stressful events can activate the Hypothalamo-Pituitary-Adrenal (HPA) axis (Kvetnansky et 
al., 2002) and increase the release of Corticotrophin Releasing Hormone (CRH) from the 
hypothalamic paraventricular nucleus, causing the secretion of adrenocorticotropin (ACTH) 
from anterior pituitary, which in turn stimulates the secretion of glucocorticoids from the 
adrenal cortex (Pacak et al., 1993; Venihaki et al., 1997). Glucocorticoids possess broad 
spectrum of actions affecting expression and regulation of genes throughout the body 
readying the organism for changes in energy and metabolism required for coping (Akil & 
Morano, 1995; Levine, 2005). Stress has been postulated to be involved in the 
etiopathogenesis of a variety of disease state including hypertension, coronary heart disease 
(Roy et al., 2001), gastric ulcers (Yadin & Thomas, 1996), diabetes (Fitzpatrick et al., 1992), 
immuno-suppression (Purret, 2001), mental depression, memory loss (Gareri et al., 2000), 
and host of other diseases. The resultant disturbances may vary depending upon type, 
intensity, and the duration of a particular stressor and the strain\sex differentiation of the 
subjects (Kioukia-Fougia et al., 2002). Different animal models for stress have been 
developed and used frequently to evaluate the anti-stress activity of compounds of both 
natural and synthetic origin.  
In an organism, diverse stressors activate a wide spectrum of interacting hormonal and 
neuronal systems resulting in behavioral (anxiety disorders, decrease in food intake, decrease 
in sexual behavior, and loss of cognitive function) and physiological responses [activation of 
pituitary adrenal axis and release of glucocorticoids into the blood stream] (Henry & 
Stephens, 1977). These stressors are stimulators of arousal and lead to autonomic (changes in 
body temperature and tachycardia) and behavioral changes; however, when arousal increases 
to stress-like levels, it results in psychiatric and physical disorders (Hennessy et al., 1979) 
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 [Figure 1].Different animal models have been developed for chronic stress induced 
neurological disorders such as the olfactory bulbectomy model, and the chronic unpredictable 
stress model. These animal models are used to screen various new chemical entities and to 
develop a better understanding of the underlying molecular pathway in chronic stress 
pathology. Stress responses are variable and there are individual differences both 
physiologically and behaviorally in how an organism perceives a perturbation and in the 
resulting adaptational/maladaptational processes (Weiner, 1992). 
Figure 1: Relationship between arousal, psychological stress, physical stress and pathology 
 
 
 
 
 
 
 
Stressor is a stimulus, either internal or external, that activates the hypothalamic pituitary 
adrenal (HPA) axis and the sympathetic nervous system resulting in physiological change 
(Maier & Watkins, 1998). Long-term exposure to stressors can cause depression, (Nirmal et 
al., 2008) post-traumatic stress disorder, and anxiety disorders. The degree of behavioral 
control that an individual has over a stressor often determines the consequence of that stressor 
and plays a key role in the development of pathological behaviors after a traumatic event 
(Christianson et al., 2009). The potency to cope with the stressors is a fundamental 
requirement for survival. Brain is the target for different stressors because of its high 
sensitivity to stress-induced degenerative conditions (Sahin&Gumuşlu, 2007). The brain 
tissue is made up of large amounts of polyunsaturated fatty acid, thus making it vulnerable to 
free radical attacks (Gutteridge, 1995). 
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I.b. Consequences of Stress 
Normal development and preservation of life and species depend on a normally functioning 
stress system. Maladaptive neuroendocrine responses, i.e., dysregulation of the stress system, 
may lead to disturbances in growth and development, and cause psychiatric, 
endocrine/metabolic, and/or autoimmune diseases or vulnerability to such diseases. 
I.c. Stress and anxiety 
According to previous reports stress induces anxiety-like behavior in both humans and 
animals (Liezmann et al., 2011). In response to stress, there is an increase in CRF levels. The 
CRF level decreases when the stressor is no longer present. Lee, et al. reported that chronic 
stress increases the length and volume of expression of CRF in areas of the brain associated 
with fear and emotion, including the amygdale (Lee et al., 2008) [Figure 2]. Such chronic 
stress changes the body’s response, and the resulting increased expression of CRF is believed 
to be the cause of health-related stress problems such as anxiety, depression, and infertility 
(Kimura et al., 2010). Exposure to stress represents an important factor for a number of 
neuropsychiatric disorders such as depression, post-traumatic stress disorder, and other 
anxiety disorders (Horstmann& Binder, 2011). There are earlier reports of enhanced 
noradrenergic or HPA axis activity in many psychopathological states such as depression and 
anxiety disorders (Boyer, 2000; Kendler, 1996).  
Oxidative stress contributes toward neuronal degeneration in the central nervous system in 
the process of aging as well as neurodegenerative diseases (Hovatta et al., 2010). The 
production of reactive oxygen species (ROS) is greatly increased under many conditions of 
toxic stress (Liu & Schubert, 2009). One of the reasons for stress-induced enhancement of 
free radicals may be the elevation of nitric oxide (NO) production (Matsumoto, 1999). This is 
further supported by the present determination of nitrite levels, which revealed significant 
increase in brain NO levels in stressed mice. The reactive nitrogen species along with ROS, 
working in concert with an inflammatory process, may play a substantial role in the 
pathogenesis of depression (Matsumoto, 1999). Stress has been shown to be responsible for 
the depletion of several free radical detoxifying enzymes such as glutathione peroxidase, 
catalase, and superoxide dismutase (Zaidi & Banu, 2004). 
This results in oxidative burden, which has been implicated in stress as well as in the 
pathogenesis of several disease states. Since brain tissues consist of a high content of PUFA 
and one of the important consequences of oxidative stress is peroxidation of membrane lipids, 
this reaction produces marked damage to the structure and function of cell membranes in 
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these tissues (Jain et al., 1991). Therefore, lipid peroxidation was supposed as the major 
biochemical alteration and consequence of oxidant-induced cell injury. Thus, the important 
consequences of stress could be attributed to stress-induced lipid peroxidation. 
 
 
Figure 2: De novo synthesis pathway of melatonin. 
I.d.Stress and immunological changes 
Stress has been associated with impaired immune function and increased susceptibility to 
infectious diseases (Connor & Leonard, 1998). It is now believed that the nervous, endocrine, 
and immune systems are so intimately connected that they should be regarded as a single 
network rather than as three separate systems (Connor & Leonard, 1998). It is widely 
accepted that psychological stress and psychiatric illness can compromise immune function 
(Leonard, 1995) and soluble mediators released by immune cells can affect the central 
nervous system, thus producing alterations in behavior. Exposure to stressful life events such 
as academic examinations and divorce was reported to cause impairments in various aspects 
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of cellular immune function (Bartrop et al., 1977). There are also reports of immune 
activation, (Bartrop et al., 1977) in addition to immunosuppression in both the depressed and 
subjects exposed to stressful life events. 
 A requirement of all studies on stress is an adequate and appropriate animal model of stress. 
An ideal animal model should be able to reproduce each of the aspects of stress response and 
should be able to mimic the natural progression of the disease. However, none of the models 
available is able to entirely reproduce stress response. Some models reproduce physical stress 
and associated neuroendocrine changes (Kvetnansky&Mikulai, 1970), whereas others better 
reproduce the psychological stress and associated behavioral changes (Marcelo et al., 2007). 
Acute models do not reproduce the neuroendocrine dysfunction whereas a chronic model 
might be able to do so. Therefore, a correct model should be used to evaluate specific aspects 
of the stress response. Each model has inherent limitations including lack of stability, lack of 
predictability of tissue damage, and lack of adjustability. And hence a literature survey of 
more than 35 years (1970-2007) was conducted based on the description of the models, 
potential utilization of the models, and value of the models for testing of new medical 
interventions for the management of stress. The purpose of this review was to assess different 
models of stress. 
I.e. Stress and Behavior 
Stress can be defined generally as responses to demands upon the body (Koob, 1999). It is the 
body’s reaction to a change that requires a physical, mental, or emotional adjustment or 
response (Selye,1936). It can come from any situation or thought that makes one feel 
frustrated, angry, nervous, or anxious. Conceptually, stress can be any threat,either real or 
perceived, to the well being of an organism and it can be of two types.Stress can be defined 
as “the generalized, non-specific response of the body to any factor that overwhelms, or 
threatens to overwhelm, the body's compensatory abilities to maintain homeostasis”. The 
following stressors can induce a stress response: physical stressors (trauma, surgery, intense 
heat or cold); chemical stressors (reduced oxygen supply, acid-base imbalance); 
physiological stressors (heavy exercise, hemorrhagic shock, pain); psychological or 
emotional stressors (anxiety, fear, sorrow); and social stressors (personal conflicts, change in 
life style). Stressors can be short-term (acute stress) or occur on a daily basis (chronic stress). 
Reactions to Stressors have been suggested to be of several types, and those of most 
importance are the “active fight/flight” pattern (sympathetic adrenal modular system) and the 
“passive” pattern (pituitary-adrenal cortical system involving the hypothalamic-pituitary- 
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adrenal HPA axis) activation of the sympathetic adrenal medullar system, with release of 
catecholamine (adrenaline and nor adrenaline), is typical during periods of acute stress. 
Hyper-activation of the HPA axis, with release of corticosteroids (cortisol), has been 
associated with individuals who are chronically stressed. Furthermore, it has been proposed 
that a hyperactive HPA axis may be programmed during the prenatal period as a result of 
foetal growth retardation. Responses to acute or chronic stress can lead to physiological 
changes which include slowed gastric emptying, elevation of blood pressure, increase in heart 
rate, mobilisation of energy stores, and decrease in blood flow to non-essential organs, for 
example the digestive system, kidneys and skin. Hormones released in response to stress can 
specifically affect appetite. Noradrenalin and corticotrophin-releasing hormone (CRH) have 
been reported to suppress appetite during stress, whereas cortical is known to stimulate 
appetite during recovery from stress. Anxiety, depression, uneasiness, anger, apathy and 
alienation are emotions that commonly accompany chronic stress. The responses to acute or 
chronic stress also include a number of modifying behaviours such alcohol consumption, 
smoking and eating. Immobilization, a severe stressor, consistently reduced ordinary food (rat 
chow) intake in rats when administered chronically and even acutely.  This stress-Induced 
inhibition of feeding behaviour may have a physiological basis. As CRF levels increase in 
response to stress, food intake decreases. Furthermore, this wasconfirmed by a study in rats 
which found CRF inhibited the hyperphagia induced by neuropeptide Y (Torres et al., 2007). 
Increased concentrations of HPA axis hormones,Particularlycorticosterone or cortisol are 
often used as an index of stress and any stimulus that causes an increase in HPA axis activity 
is identified as stressor (Nagaraja et al., 2006). 
The stress response activates the SNS as well as the HPA axis. The SNS stimulates the 
adrenal glands to release (nor) epinephrine, which can be indirectly measured via salivary 
alpha-amylase (SAA) (Nater and Rohleder, 2009). Activation of the HPA axis leads to a 
release of CRH, adrenocorticotropic hormone, and glucocorticoids such as cortisol, the major 
stress hormones in humans. cortical readily enters the brain and modulates cortical as well as 
sub cortical structures involved in learning and memory, e.g. the amygdala, the hippocampus 
or the prefrontal cortex (Merz et al., 2013; Wolf, 2009). 
The central control stations of the stress response are located in the hypothalamus and the 
brain stem. CRH neurons of the par ventricular nucleus initiate the stress response and 
comprise the principal hypothalamic regulator of the HPA axis. CRH stimulates the secretion 
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of ACTH from the anterior pituitary. Circulating ACTH acts on the zone fasciculate of the 
adrenal cortex where it stimulates the release of cortisol or corticosterone. In turn, cortisol 
feeds back to the brain to shut off further cortisol secretion. This negative feedback loop 
protects the organism from prolonged, detrimental cortisol exposure and keeps its 
concentration within a wide but stable operating range. The SAM originates in the locus 
ceruleus, and together with the HPA axis builds the effector limbs of the stress response. 
Cortisol stimulates hunger and feeding, and that adrenaline is part of the fight/flight response 
which shuts down digestion, we hypothesize that threat stress will stimulate eating more than 
challenge stress. One study comparing chronic physical stress (foot shock) vsEmotional stress 
in rats revealed that physical stress reduced consumption and preference for saccharin 
drinkcompared to water, whereas emotional stress increasedsaccharin preference and 
consumption compared to water. 
 Others found increased preference for palatable food with physical stress (foot shock), but 
only when rats were previously exposed to a history of dietary restriction. Repeated stressors 
in rats generally seem to reduce food intake (FI) and body weight (bw) (Epel et al., 2007). 
Oxidative stress contributes toward neuronal degeneration in the CNS in the process of aging 
as well as neurodegenerative diseases (Hovatta et al., 2010). The production of ROS is 
greatly increased under many conditions of toxic stress (Liu & Schubert, 2009). One of the 
reasons for stress-induced enhancement of free radicals may be the elevation of NO 
production (Matsumoto et al., 1999).  
This is further supported by the present determination of Nitrite levels, which revealed 
significant increase in brain NO levels in stressed mice. The reactive nitrogen species along 
with ROS, working in concert with an inflammatory process, may play a substantial role in 
the pathogenesis of depression (Matsumoto et al., 1999). Stress has been shown to be 
responsible for the depletion of several free radical detoxifying enzymes such as glutathione 
peroxides, catalase, and superoxide dismutase (Zaidi & Banu, 2004).This results in oxidative 
burden, which has been implicated in stress as well as in the pathogenesis of several disease 
states. Since brain tissues consist of a high content of polyunsaturated fatty acids and one of 
the important consequences of oxidative stress is peroxidation of membrane lipids, this 
reaction produces marked damage to the structure and function of cell membranes in these 
tissues (Jain et al., 1991). Therefore, lipidperoxidation was supposed as the 
majorbiochemical alteration and consequence of oxidant-induced cell injury. Thus, the 
important consequences of stress could be attributed to stress-induced lipid peroxidation. 
Chapter 1                                                                                         Introduction 
 
     Dept. of Pharmacology       8        J.K.K.Nattraja College of Pharmacy    
 
Everyone has their own coping strategies to handle stress, and some strategies are healthier 
than others. While some people are able to deal with stress without changing their normal 
behaviour, it is rare that stress does not have some adverse affects on an individual. Often 
times,thoseaffects reach the realm of eating behaviours. The investigation into whether stress 
leads to overconsumption or reduced food intake is widespread among different groups of 
humans and animals. Not only is the amount of intake examined, but also whether stress can 
invoke changes in the chosen types of food to eat. While there are clear biological changes 
that occur under stress, there are also emotional factors that can influence eating habits during 
stressful situations. 
 Whether the individual is a restrained or emotional eater can change the way food is used to 
cope with stress. With the increasing problem of obesity and the increased levels of stress 
born by individuals, the correlation between stress and eatingbehaviours may help in 
counteracting the obesity epidemic. Stress is a very crucial factor in the maintenance ofhealth 
and disease   Stress induces changes in emotionalbehavior and anxiety like state, which are 
associated withoxidative damage, that is, free radical damage. Acuteimmobilization stress 
triggers numerous cellular cascadesthat lead to increase in ROS production. Because of 
thebrain high oxygenconsumption, abundant lipid content and relative paucity of antioxidant 
enzymes, the centralnervous system is highly vulnerable to free radical damage. 
Immobilization stress has also been reported to induce2-3-fold higher rise of plasma cortisol 
level;increasedcortisol level has been linked with anxiety-like behavior. It is been reported 
that stress triggers the motor alteration in different animal models and central nucleus of 
amygdale is important inmodulating affective response to stress. Natural productssuch as 
bioflavonoids possess very goodantioxidant proper and inhibit lipid per oxidation 
inbiologicalmembrane. Hesperidin is such natural bioflavonoidthat possesses very good 
antioxidant property and it has been proved to be very effective in various neurobehavioral 
diseases. 
Antioxidants (AOs) are present in a variety of plants(including fruits, berries, and nuts) and 
promote health byremoving damaged free-radicals from the cellular environment,inhibiting 
the production of inflammatory mediators and blocking carcinogenic processes.The 
therapeutic application of a number of AOs in disease is currentlyunder investigation. 
Phloretin, present at high levels infruits, such as apples, pears, and strawberries, can exertanti-
inflammatory and immunosuppressive effects on bothlymphoid- and myeloid-derived cells. 
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Developing an effective drug delivery system with the ability of crossing the blood brain 
barrier (BBB) is the crucial point intreating diseases of the Human central nervous system 
(CNS)effectively. Many potential drugs have been abandoned duringtheir development for 
their poor ability to cross the BBB insufficient quantities to produce a therapeutic effect. The 
BBB isnot only an anatomical barrier to the free movement of solutesbetween the blood and 
brain, but also a transport and metabolicbarrier. Consequently, developing tools and methods 
thatallow the therapeutic agents to delivery to the brain safely andeffectively in vivo is 
important. 
 
 
 
  
 
 
  
ANIMAL MODELS COMMONLY USED 
I. Physical stress models  
Animal models of stress that use physical stress can be subdivided into: 
1. Temperature fluctuation induced stress:  
a. Cold 
b. Heat 
c. Intense radiation 
d. Noise 
e. Pain (chemical & physical) 
f. Vibration and many others  
II. Psychological stress models  
Animal models of stress that use psychological stress can be subdivided into:  
i. Neonatal isolation induced stress  
ii. Predatory stress  
Different Types of Stress (Based on the 
Time Period of Application ofStressor) 
Acute 
Stress 
(Single Application of 
Stressor) 
Chronic 
Stress 
(Application of Stressor for 
a Long Period of Time) 
Chronic Variable Stress 
(Repeated Application of 
different types of stressors 
of Variable Intensity) 
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iii. Day-night light change induced stress  
iv. Noise induced stress.  
III. Chronic unpredictable stress models 
1) Stressors that challenge cardiovascular and metabolic homeostasis 
2) Social stressors reflecting disturbed interaction among individuals 
Different stressors of mild to moderate intensity are applied on variable basis so as to prevent 
the emergence of adaptation or resistance to one particular type of stressor. It involves the use 
of both physical and psychological stress models in a random way. 
 
II. PHYSICAL STRESS MODELS  
a. Temperature fluctuation induced stress 
Acute change in temperature leads to stressful conditions by activation of temperature 
regulatory centre in the hypothalamus and subsequently HPA axis. It leads to acute release of 
adrenocortical hormones in the blood stream responsible for acute stressful response 
(Sapolsky et al., 1986). A sharp decrease in temperature using either cold water or freezer has 
been used frequently to induce acute stress.  
i. Immersion in Cold Water (ICW)  
In this method, the rats are placed individually in a tank of cold water (depth = 15.5 cm; 
temperature = 15-20°C) where they either swim or remain in an upright position, keeping 
their heads above water level (Retana-Marquez et al., 2003; Iwona et al., 2003; Fernandez-
Landiera, 2004; Yun et al., 2003). This situation lasts for 15 minutes unless the rats sink. In 
that event, rats are removed before the cutoff time and are not included in the experiments. 
For acute stress, rats are sacrificed 30 minutes after the stress exposure. For chronic stress, 
animals are exposed to this stressor for 7-10 days. Rats are sacrificed 1 h after the last stress 
session. The major advantage of this type of stressor is that acute stress can be achieved in a 
relatively short period of time. However the major drawback of this model is that the body 
adapts to change in temperature on chronic exposure to low temperature and hence stress 
response gets highly diminished (Pitman et al., 1988; Blustein et al., 1998).  
ii. Cold environment isolation  
In this method, rats are individually kept in a freezer with a temperature maintained at 4°C. 
The rats are kept for 15 minutes once for acute stress and for 7-10 days to develop chronic 
stress (Kvetnansky et al., 1971). This sharp fall in temperature leads to a sharp increase in the 
level of adrenocorticoids, as explained above culminating in the development of stress 
response (Kvetnansky et al., 2002; Staratakis&Chrousos, 1995). Unlike the ICW model, rats 
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are prevented from drowning in cold water hence it is relatively safe model however it also 
suffers from same drawback of development of resistance/adaptation on chronic exposure.  
iii.Immobilization induced stress  
Immobilization has been used extensively as a stressor for the study of stress-related 
biological, biochemical and physiological responses in animals (Kvetnansky&Mikulai, 1970; 
Kasuga et al., 1999; Marty et al., 1997). Immobilization can be produced in two different 
ways. Animal can be either kept immobilized in a semi cylindrical acrylic tube (4.5 cm 
diameter and 12 cm long) with proper holes in it for air to pass (Das et al., 2000). Another 
way is to keep the animal with its limbs stretched on a board and its limbs are immobilized 
with adhesive tape. Movement of head is restricted by keeping the head in a metal loop coiled 
around the neck. The rats are kept immobilized in either of the above two ways for 150 
minutes once to produce acute stress and for 7-10 days to produce chronic stress 
(Dronjak&Gavrilovic, 2006). The major advantage of using immobilization as a model of 
stress is that it produces an inescapable physical and mental stress to which adaptation is 
seldom exhibited (Kasuga et al., 1999). 
iv. Electric foot shock induced stress 
Electric foot shock (EFS) of mild intensity has also been used as a stressor. Rodents are very 
susceptible even to mild shock and exhibit rapid stress response. Researchers have used 
electric foot shock of varying degree to produce stressful conditions and hence to evaluate 
adaptogenic activity of various compounds. Stress by electric foot shock is given by placing 
the rats individually in a chamber with an electrified floor. Rats receive unavoidable electric 
foot shocks with an intensity of 3 mA, 200 ms of duration and a frequency of 1 per second 
over a 5-min period. For acute stress response, the rats are exposed once and sacrificed after 
15 minutes of stress. Chronic stress is also produced by repeating the same treatment for 7-10 
days and rats are sacrificed 1 h after the last stress session (Retana-Marquez et al., 2003). 
Some researchers have modified the method in which rats are subjected to inescapable 
electric foot shock for 60 minutes (0.15 mA shock, on a variable interval schedule with a 
mean inter shock interval of 60 seconds) (Taysse et al., 2005). The biggest advantage of this 
model is that it effectively produces high degree of stress in the animal. The major 
disadvantage of this model is the hazard of electric shock causing death of the animal and 
special caution that is required to perform this methodology. 
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v. Forced swimming induced stress  
It is the tendency of the living being to escape or avoid a noxious stimuli/condition. If the 
animal is not able to escape the stressful stimuli or it feels threatened, the animal will show 
stress response. This principle is used for developing forced swimming model for inducing 
stress in laboratory animals. In order to produce swimming induced stress, rats are made to 
swim in a cylinder (30 cm diameter and filled to a height of 20 cm with 15 cm of space above 
the head of the rat) for a single session of 2 h duration for acute stress, or for one 2 h session 
a day for five consecutive days for chronic stress (Ferry et al., 1991). Some authors have 
used forced swimming in warm (20°C) water for 3 minutes with the total session lasting for 1 
h (Kitchen & Pinker, 1990). Although forced swimming induced stress is a highly safe 
model, adaptation to chronic swimming induced stress has been reported and inter-strain 
differences between rats to forced swimming behavior have also been documented (Armario 
et al., 1995). 
III. PSYCOLOGICAL STRESS MODELS  
a. Neonatal isolation stress  
Early life events have profound consequences on subsequent quality of life. It has been 
shown that the early life stress of neonatal isolation in rats has immediate and enduring neural 
and behavioral effects (Kuhn et al., 1990). Such effects may reflect, in part, stress-induced 
morphological changes in hippocampus and other brain regions (Kosten et al., 2005b). In 
fact, the hippocampus provides negative feedback regulation of the hypothalamic-pituitary-
adrenal (HPA) axis (Herman &Cullinan, 1997) and hence neonatal isolation induced stress 
can represent the stress response that may lead to neuro-degeneration at an early stage of life. 
This stress procedure is also useful in evaluating the effect of stress on cognition and memory 
development. In the neonatal isolation procedure, the litter of the inbred strain is removed 
from the cage on second day after the birth, weighed and placed individually in an opaque 
plastic container (9 cm diameter and 8 cm deep) with no bedding for 1 h (between 09:00 and 
12:00) in a heated (30°C), humidity controlled chamber with white noise to mask other pups 
calls. The chamber has to be located in a room separate from animal colony facility. 
Containers are placed 20-30 cm apart. After 1 h period the litters are placed back with their 
dams in home cage (Kosten et al., 2000; Kosten et al., 2004). This isolation procedure 
continues up to 8 days and hence it is used to induce chronic stress only. Neonatal isolation 
stress model has be used extensively to demonstrate the effect of early lifetime stress on 
vulnerability to addiction (Kosten et al., 2005a), and response to psychostimulants by 
impairment of hippocampal-dependent context induced fear in adult male rats.  
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b. Predatory stress  
Direct encounter of an animal with its natural predator is one of the most stressful and 
anxiogenic event it can face and it leads to rapid development of „flight or fight‟ response 
(Lupien et al., 2006). Exposure of rodents to natural predators or to their odors may induce 
stress like states (Adamec& Shallow, 1993). Under such circumstances, there is rapid 
sympathetic activation leading to rise in the levels of adrenocorticoids in blood causing acute 
stress response to develop. Direct encounter with a predator has been effectively used to 
evaluate the biochemical and physiological changes produced during such stressful 
conditions (Marilia et al., 2007). Predatory stress in mice is induced by series of short 
exposures to natural predator like cat (Blanchard & Blanchard, 1989) or to any substance 
having the odor of cat like the fecal pellets of cat (Berton et al., 1998). In one of the methods, 
mice are placed individually in different cages and after four initial 20-min cage habituation 
sessions each subject is submitted to two randomly-assigned 20-min predator confrontation 
sessions. Change in behavioral pattern such as locomotion, shrieking like voices and 
endocrinological changes after the stress exposure are observed (Blanchard et al., 1998). 
Another free-exploration test (Griebel et al., 1993) was used consists of a PVC box 
(30x20x20 cm) covered with Plexiglas and subdivided into six equal square exploratory 
units, which are all interconnected by small entries. It could be divided in half lengthwise by 
closing three temporary partitions. Approximately 20 h before cat exposure, each subject is 
placed in one half of the apparatus with the temporary partitions in place, in order to be 
familiarized with it. The floor of this half was covered with fresh sawdust and the animal is 
given unlimited access to food and water. On the test day, mice of each strain are randomly 
allocated to the following four groups.  
(a) Naive clay: animals are exposed to both familiar and novel compartments by removal of 
the temporary partitions. The novel compartment contains three modeling odor-free clay 
pellets.  
(b) Naive feces: animals are exposed to both familiar and novel compartments. The novel 
compartment contains three cat feces pellets.  
(c) Exposed clay: subjects are removed from the free-exploration box and confronted 
individually with a cat during a 5 min session. The cat cage consists of a PVC box (82x56x62 
cm) subdivided into two compartments, one containing the cat, the other the mouse. 
Separation consists of a transparent PVC wall with holes allowing the cat to reach the other 
side with its paws. The mouse is then put back in the free-exploration apparatus and is 
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exposed 1 h later to both familiar and novel compartments. The novel compartment contains 
three modeling odor-free clay pellets.  
(d) Exposed feces: same as previous group, but the novel compartment contains three pellets 
of feces from the cat used during exposure. The behavior of the mouse is observed under red 
light for 5 min via a closed circuit TV camera by an observer located in an adjacent room.  
The following parameters are recorded:  
(a) Time spent in the novel compartment; (b) total unit entries and (c) total number of 
rearings.  
The results are expressed as mean percentage of time spent in the novel compartment, mean 
total number of novel unit changes, and mean total number of rearings. Marmosets 
(Callithrixpenicillata) have also been employed for induction of predatory stress in a test 
battery known as Marmoset Predator Confrontation Test [MPCT] (Cilia & Piper, 1997). This 
model compares the behavioral response of experienced versus naïve adult black tufted-ear 
marmosets in confrontation with a taxidermized wild-cat predator stimulus. After four initial 
20-min cage habituation sessions, each subject is submitted to two randomly-assigned 20-min 
predator confrontation sessions. Confrontation with the predator induces significant 
behavioral changes; i.e., proximic avoidance and tsik-tsikalarm call. Anti-stress drug 
administration, concomitant to predator exposure, reverses the behavioral changes observed 
(Barros et al., 2004). Predator induced stress is an established model to induce short term 
acute stress response but its major disadvantage is development of habituation to predator 
exposure hence the use of this model for inducing stress is justified for developing only acute 
stress.  
c. Day-night light change induced stress 
Changes in the circadian rhythm have profound effect on physical and psychological well 
being of an individual (Atcheson& Tyler, 1975). Laboratory animals, when subjected to 
abrupt changes in day-night light pattern, exhibit acute stress response (Kosten et al., 2005b). 
Changes in circadian rhythms are regulated by pineal gland through the secretion of 
melatonin (Nicholsonet al., 1985). Melatonin is released from the pineal gland in response to 
dark or dim light where as its functional antagonist serotonin is secreted in response to bright 
light. It is this serotonin-melatonin cycle that is responsible for regulation of sleep-awake 
state of the body (Bermudez et al., 1983; Hamm et al., 1983). To induce stress, cages of rat or 
mice are kept under bright light from 19:00 h over night (in the dark phase) and cages are 
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kept in dark room with no light from 12:00 h in the light phase for 180 minutes for 7-10 days 
(Marcelo et al., 2007). This method is suitable for inducing short term stress response. 
Generation of stress can be evaluated by measuring the biochemical parameters associated 
with chronic stress response (Rai et al., 2003). The major disadvantage of this model is that it 
can be effectively used to generate short term stress response as on repeated exposure to this 
type of stressor, the animal adapts to the changed day-night light pattern. This major 
drawback can be minimized by using this model as a part of chronic unpredictable stress 
protocol. 
 
d. Noise induced stress  
Noise as a stressful stimulus is a widely accepted fact. A large number of people are exposed 
to potentially hazardous levels of noise levels in daily modern life. Experimental studies have 
demonstrated ultra structural modifications in rat cardiomyocytes mainly in mitochondria due 
to noise stress. These subcellular alterations are related to an imbalance in calcium 
homeostasis, which is supposed to be sustained by increased catecholamine innervations 
(Paparelli et al., 1992). When noise exposure of any kind exceeds 90 dB, noise becomes a 
stressor (Ramsey, 1982). Noise stress has a depletory effect on free radical scavenging 
enzymes in the brain leading to moderate to severe oxidative stress (Samson et al., 2005) 
which can be a potential basis for hearing loss (Fechter, 2005). Noise stress in laboratory rats 
can be produced by loudspeakers (15 W), driven by a white noise generator (0-26 kHz), 
installed 30 cm above the cage. Thus a noise level can be set at 100 dB or above uniformly 
throughout the cage and can be monitored by a sound level meter. Each animal to be treated 
is exposed to noise stress for 4 h/day for 15 days. Control group rats are also kept in the 
above described cage during the corresponding period of time, without noise stimulation to 
avoid the influence of handling stress on evaluation of effects due to noise exposure 
(Ravindran et al., 2005; Manikandan& Devi, 2005). The effect of noise stress exposure can 
be determined by estimating the brain biogenic amine level.  
iv. Chronic variable (unpredictable) stress models  
The major disadvantage of both physical stress models and psychological stress models is the 
development of adaptation / resistance on chronic exposure. The changes in physiological 
and behavioral responses to chronic stress can be related to the adaptation of the HPA axis. 
When the same stressor is repeated, the HPA response undergoes desensitization or become 
stable as it has been reported that rodents repeatedly exposed to restraint stress exhibited a 
habituated corticosterone response, when they were subsequently challenged with an acute 
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exposure to restraint (Magarinos& Evans, 1995; Gadek-Michalska&Bugajski, 2003). On the 
other hand, the exposure to a multiple stress paradigm produced continued elevation in 
corticosterone levels, when the animals were subsequently subjected to acute restraint stress 
(Magarinos& Evans, 1995). It has also been suggested that the adaptations of HPA axis 
depend on type, duration and severity of the stress regime (Blanchard et al., 1998; Gadek-
Michalska&Bugajski, 2003). To prevent the development of resistance, Chronic 
Unpredictable Stress (CUS) models have been developed which involve the use of various 
physical and psychological stressors in a predetermined manner so that the animal is not able 
to adapt to the stressor. Adaptation to one type of stressor has been effectively prevented by 
employing various stressors such as immobilization stressor for 15 minutes followed by 
overnight sleep deprivation and rotation of the cage at a predetermined speed (horizontal 
shakes at high speed) for 50 minutes followed by swim stress in water (20ºC) of 4 minutes 
(Ortiz et al., 1996). Wetting the saw dust bedding of the animal all day to restrict movement 
followed by electric foot shock (ten shocks of one second duration each, in an unpredictable 
manner, at the intensity level of 0.4-1.8 mA) and stroboscopic light (for 13 h, 10 Hz) has also 
been used as a part of CUS protocol (Margus et al., 2007).  
Some researchers have used exposure to predator odor induced stress as a part of CUS 
protocol, in which mice are placed in a novel cage containing cat litter soiled with cat feces 
and urine (Anisman et al., 2007). Various authors have modified the stress models in order to 
accommodate them in their respective CUS protocol. Other additional stressors that have 
been applied as a part of CUS protocol are tail pinch with a clothes-pin placed 1 cm distal 
from the base of the tail for 5 min, strong illumination during predicted dark phase for 12 h, 
movement restriction in a small cage (11 cm x16 cm x 7 cm) for 2 h (Ortiz et al., 1996), ether 
anaesthesia until loss of reflex (Renard et al., 2005), and subcutaneous 0.9% saline injection 
(Ladd et al., 2004). Chronic variable stress models have been proven to be more useful as 
they are devoid of the problem of resistance in the animal species towards the commonly 
used stressors and also have the advantage of the development of effective and long-term 
stress response. Thus CUS models are nowadays the preferred models for generation of a 
stress response. 
Stress has been postulated to be involved in the etiopathogenesis of a variety of disease state 
including hypertension, coronary heart disease (Roy et al., 2001), gastric ulcers (Yadin& 
Thomas, 1996), diabetes (Fitzpatrick et al., 1992), immunosuppression (Purret, 2001), 
mental depression, memory loss (Gareri et al., 2000), and host of other diseases. 
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v. Common Motifs in Neurodegeneration  
Neurodegenerative disorders such as AD and PD account for a significant and increasing 
proportion of morbidity and mortality in the developed world (Hebert et al., 2001). Largely 
as a result of increased life expectancy and changing population demographics (i.e., the aging 
of baby boomers), neurodegenerative dementias and neurodegenerative movement disorders 
are becoming more common (Brookmeyer et al., 1998; Samii et al., 2004). As our population 
ages, an improved understanding of these diseases will be vital to developing more effective 
therapies and combating the staggering personal, social, and economic costs of these diseases 
(Ernst et al., 1997). Unifying theories of pathogenesis in neurodegenerative disease provide 
an avenue for developing therapeutic strategies with broad applicability for disease 
prevention and an opportunity for decreasing morbidity and mortality from these disorders in 
the elderly population (Forman et al., 2004). Converging lines of investigation have revealed 
a potential single common pathogenic mechanism underlying many diverse 
neurodegenerative disorders. 
v.a.Mechanisms of Neuronal Death 
Acute injury to cells causes them to undergo necrosis, recognized pathologically by cell 
swelling, vacuolization and lysis, and associated with calcium (Ca2+) overload of the cells 
and membrane damage. Necrotic cells typically spill their contents into the surrounding 
tissue, evoking an inflammatory response. Cells can also die by apoptosis or programmed 
cell death, a slower process that occurs normally during development and is essential for 
many processes throughout life, for example development, immune regulation and tissue 
remodeling.Apoptosis, as well as necrosis, occurs in many neurodegenerative disorders 
including acute conditions such as stroke and head injury (Bredesen, 1995). The distinction 
between necrosis and apoptosis as processes leading to neurodegeneration is not absolute, 
for challenges such as excitotoxicity and oxidative stress may be enough to kill cells directly 
by necrosis, or, if less intense, may induce them to undergo apoptosis. Both processes, 
therefore, represent possible targets for putative neuroprotective drug therapy.  
Pharmacological interference with the apoptotic pathway may become possible in the future, 
but for the present, most efforts are directed at the processes involved in cell necrosis, and at 
compensating pharmacologically for the neuronal loss.In recent years there has been an 
increasing interest in the studies on Neurodegeneration, including the physiological or 
programmed neuronal death and the cell disruption occurring as a consequence of necrosis. 
This interest has been greatly stimulated by the fact that precipitation and localization of 
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neuronal destruction is a central event in the course of many acute and chronic disorders of 
the CNS. These disorders include stroke (anoxia-ischemia), hypoglycemia, cerebral trauma, 
epilepsy and several devastating neurodegenerative diseases, such as ALS, PD, AD and HD. 
Among the cellular mechanisms possibly involved in neuronal death in neurodegenerative 
disorders, three closely related factors seem to play important roles: (1) the generation of 
reactive oxygen species (ROS) or free radicals, (2) the over activation of synaptic excitatory 
amino acid (EAA) receptors, and (3) the increase in cytoplasm free Ca2+ concentration and 
(4) infection. As shown in Fig. 1, the links between these factors are multiple and an initial 
event may lead, in a cascade manner, to the generation of further alterations. In addition to 
these, several other factors like selective vulnerability and exquisite specificity of the 
disease process for particular types of neurons; genetic predisposition; excitotoxicity; 
oxidative stress; environmental triggers – infectious agents, toxins, brain injury; aging and 
disruption in energy metabolism (Standaert et al., 2009).  
v.b.Oxidative Stress 
Oxidative stress means an unbalance between pro-oxidants and antioxidant mechanisms. This 
results in excessive oxidative metabolism. This stress can be due to several environmental 
factors such as exposure to pollutants, alcohol, medication infections, poor diet, toxins, 
radiation etc. Oxidative damage to DNA, proteins, and other macromolecules may lead to a 
wide range of human diseases most notably heart disease and cancer. Free radicals are 
capable of attacking the healthy cells of the body by oxidative stress. This may lead to 
damage, disease and severe disorders. Cell damage caused by free radicals appears to be a 
major contributor to aging and diseases like cancer, heart disease, decline in brain function, 
decline in immune system etc. 
v.c. Lipopolysaccharide 
Lipopolysaccharide (LPS), an endotoxin of the gram-negative bacteria cell wall, is the major 
cause of sepsis. Endotoxins play a major role in developing stress and has a cascading effect 
on the functioning of the defense mechanisms, neuroendocrine, neurotransmitter, behavior, 
cognition etc., 
Exposure to stressful events like infection, often results in long-lasting changes in the 
response of a variety of systems. For example, repeated exposure to the same stressor 
(homotypic stress) often results in habituation of the hypothalamic–pituitary–adrenal (HPA) 
axis and brain stem catecholaminergic activity. Conversely, exposure to a test stressor that is 
different (heterotypic stress) from that used during the initial repeated exposure results in 
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sensitization of the HPA axis and brain stem catecholaminergic activity. In addition, a single 
exposure to a stressor has been shown to sensitize central pathways involved in drug reward 
and neuroendocrine responses (van Dijken et al., 1993).LPS is one of the most common 
inflammogens used to investigate the impact of inflammation on neuron death. The 
production of intracellular ROS results from the process of normal cellular function and 
metabolism and may originate from multiple cellular sources, such as xanthine oxidase, 
mitochondrial electron transport, NADPH oxidase, peroxisomes, and the endoplasmic 
reticulum. The identification of ROS as a primary factor in LPS-mediated neurodegeneration, 
the localization of the source of ROS causing the neurotoxin effect and the elucidation of the 
signaling Pathway driving microglia over-Activation is of paramount importance to 
understanding the molecular mechanisms of the neurodegenerative disease state. The brain is 
particularly susceptible to the effects of ROS due to its high consumption of oxygen and 
modest antioxidant defenses. These features are coupled with high concentrations of 
polyunsaturated fatty acids (PUFA) which are easily oxidized and known to generate oxygen 
radicals following an insult (Rice-Evans & Burdon, 1993). 
vi. Herbal Medicines 
In traditional practices of medicine, numerous plants have been used to treat cognitive 
disorders, including neurodegenerative diseases such as AD and other memory related 
disorders. Various studies have been undergone to identifying potential new drugs from plant 
sources, including those for memory disorders. There are numerous drugs available in market 
that have been isolated from plants, e.g. alkaloids from plant sources have been investigated 
for their potential in AD therapy, and are now in clinical use. Usually herbal preparations are 
well tolerated but they may have harmful side-effects, including interactions with 
pharmaceuticals (Howes& Houghton., 2003). Herbal medicines, such as, Ginkgo biloba, 
Bacopamonier (Bramhi) (Das et al., 2002), Shankhpushpi, etc, has been found to increase 
memory power. 
vi.a Herbal Medicine as Antioxidants 
Antioxidants are man-made or natural substances that may prevent or delay some types of 
cell damage. Antioxidants are found in many foods, including fruits and vegetables. They are 
also available as dietary supplements. Some of the antioxidants found in natural substances 
are beta-carotene, lutein, lycopene, selenium, vitamin A, vitamin C, vitamin E etc., 
vegetables and fruits are rich sources of antioxidants. There is good evidence that eating a 
diet with lots of vegetables and fruits is healthy and lowers risks of certain diseases. But it 
Chapter 1                                                                                         Introduction 
 
     Dept. of Pharmacology       20        J.K.K.Nattraja College of Pharmacy    
 
isn't clear whether this is because of the antioxidants, something else in the foods, or other 
factors.High-dose supplements of antioxidants may be linked to health risks in some cases. 
For example, high doses of beta-carotene may increase the risk of lung cancer in smokers. 
High doses of vitamin E may Increase risks of prostate cancer and one type of stroke.  
Antioxidant supplements may also interact with some medicines. To minimize risk, tell you 
of your health care providers about any antioxidants you use. All living organisms utilize 
oxygen to metabolize and use the dietary nutrients in order to produce energy for survival 
oxygen thus is a vital component for living. Oxygen meditates chemical reactions that 
metabolize fats, proteins, and carbohydrates to produce energy. While oxygen is one of the 
most essential components for living, it is also a double edged sword. Oxygen is a highly 
reactive atom that is capable of becoming part of potentially damaging molecules commonly 
called “free radicals. Apart from diet, the body also has several antioxidant mechanisms that 
can protect itself from ROS mediated damage. The antioxidant enzymes – glutathione 
peroxidase, catalase, and superoxide dismutase are such enzymes. They require micronutrient 
cofactors such as selenium, iron, copper, zinc, and manganese for their activity. It has been 
suggested that an inadequate dietary intake of these trace minerals may also lead to low 
antioxidant activity. 
vi.b. Phytochemicals 
As human life expectancy has increased, so too has the incidence of stress related 
neurodegenerative disorders such as AD, PD and HD. Phytochemicals, especially flavonoids 
have a wide range of medicinal actions, and throughout history, they have been used to treat 
many different types of diseases. In the treatment of many diseases, antioxidant therapy plays 
a key role, so current research is now directed towards finding naturally occurring antioxidant 
of plant origin.Photochemical are non-nutritive plant chemicals that have protective or 
disease preventive properties.  
It is well-known that plants produce these chemicals to protect themselves but recent 
researches demonstrate that they can also protect humans against diseases (Viswanatha et al., 
2012) some of the well-known phytochemicals are flavonoids in citrus fruits. In Indian 
system of medicine, phytochemicals are being used to alleviate, ameliorate and/or treat many 
illnesses successfully. The flavonoids are also used as a nutritional supplement for any 
ailments. Hesperidin, a flavone glycoside copiously found in peels of sweet orange and 
lemon, is an inexpensive by-product of citrus cultivation. 
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Hesperidin is effectively used as a supplemental agent andit has been reported to possess 
significant anti-inflammatory, analgesic, antifungal, antiviral antioxidant, and anticancer 
activities (Vaibav et al, 2010).But there is lack of studies related to neuroprotective effect of 
hesperidin in (LPS)-induced endotoxicNeurodegeneration. The general behaviour, anxiolytic 
and antidepressant activity along with antioxidant enzyme and non-enzyme status will be 
analysed in rat brain,along with the pattern of food and water intake for the first time to 
assess the protective effect of hesperidin against endotoxin-induced Neurodegeneration. We 
anticipate that the behavioural tests used in the present study could contribute to the 
evaluation of hesperidin against endotoxin-induced neurodegeneration and may shed an 
insight into the mechanism of action. Hence, a special attention is focused to understand the 
treatment of neurodegenerative diseases by natural flavonones, preferably hesperidin.There 
are, indeed, a multitude of paradigms assessing various aspects of the behavioral performance 
like anxiety and depression, changes in feeding pattern, body mass and biochemical analysis. 
Till now, some of the paradigms have not been used at all in the evaluation of hesperidin 
against behavioral consequences of adult rats when challenged with LPS.Hence, in order to 
contribute further to the knowledge of therapeutic effect of hesperidin, and its rich 
abundance, the objective of the present study is to subject hesperidin to test against 
endotoxin-induced neurodegeneration and in rat models. 
vi.c. Flavonoids 
Over the last decade, renewed interest has been shown toward these flavonoid compounds, 
with some 4000 having been isolated so far. Only a handfulhas been extensively studied for 
their medicinal properties (Rice-Evans, 2004). In the plant kingdom, they function as special 
pigments designed to prevent sunlight and toxin-induced free radical damage.Recent studies 
have shown some rather remarkable medicinal properties of flavonoid compounds. For 
example, some havebeen shown to have anticancer properties, antiviral and antibacterial 
activity (Hirano, 1989), and immune stimulating qualities (Wacker&Hilbig, 1978), as well as, 
offering protection against strokes and  heart attacks (Stimpel et al., 1984; Hertog et al., 
1993; Krieglstein et al., 1986).The medicinal properties of plants have been investigated in  
the light of recent scientific developments throughout the world, due to their potent 
Pharmacological activities, low toxicity, and economic viability. Ayurveda has a clinical 
specialty called Rasayana, which prevents diseases and counteracts the ageing process by 
means of optimization of homeostasis. It has been reported that the Rsayanas are 
rejuvenators, nutritional supplements, and strong antioxidants (ShanmugaSundaram & 
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Gowtham, 2012).It is estimated that nearly 25% of modern drugs directly or indirectly 
originated from plants (De Smet, 2002). There are more than 120 traditional medicines in use 
for the therapy of CNS disorders in Asian countries. Some of their therapeutic effects have 
been confirmed by recent clinical studies. An ethnopharmacological approach has provided a 
potentially rich source for drug discovery and development (Harvey, 1999).  
 
Many drugs currently available in Western medicine were originally isolated from plants. 
Although a large number of compounds have been isolated, most of these resources have not 
yet been fully characterized for pharmacological purposes.Although some plants have shown 
beneficial effects, further studies regarding the compounds responsible for activity are 
necessary to identify which compounds are responsible for the pharmacological activities 
observed, or if compounds act synergistically to enhance activity. For many plants and 
compounds that have shown activities relevant to therapy, clinical data are very limited. 
Clinical efficacy and potential toxicity of active plants and compounds in larger trials require 
further assessment before recommendations regarding their use can be established. Currently, 
drug research focuses on mechanism based drug development and understanding the etiology 
of the disease. Although advances in the symptomatic therapy of the neurodegenerative 
disorders have improved the lives of many patients, the drugs still have some drawbacks 
(Melanie-Jayne & Peter, 2003). 
 
There has been a recent explosion of interest by research scientists in the flavonoid 
compounds, with a multitude of medically useful properties having been demonstrated in 
experimental, as well as, clinical studies of flavonoids. For instance, flavonoids have been 
shown to act as powerful free radical scavengers for multitude of free radical species, even 
the powerful proxynitrite radical. In addition, several flavonoids have shown powerful metal-
chelating properties, especially for iron and copper, two of the most potent-free radical 
catalysts (Jovanovic, 1998). Of equal Importance are several studies that have shown that 
flavonoids interact with cell membranes, improving their fluidity, thereby protecting them 
from lipid peroxidation (Morel et al., 1998). Along these same lines is the protection of 
microvessels in the nervous system by specific flavonoids from free radical damage (Saija et 
al., 1995; Ratty & Das, 1988). This not only prevents leakage of such vessels, but has been 
shown to preserve the blood–brain barrier as well (Kuttan et al., 1981). There is also evidence 
that several of the flavonoids can inhibit platelet adhesiveness, thereby preventing strokes 
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(Robert et al., 1977). Finally, some of the flavonoids have the unique ability to inhibit certain 
enzymes, such as the COX-2 enzyme (Tzeng et al., 1991; Kim et al., 1998). 
vi.d. Flavonoids and Inflammation 
Neuroinflammation plays a vital role in neurodegenerative diseases and its inhibition by 
neuroprotective herbs, the antioxidant activity of herbal extracts is certainly another 
important aspect of neuro protection. A variety of herbal extracts and their components have 
been demonstrated to exert neuroprotective effects associated with antioxidant activities, 
either by directly stimulating antioxidant response genes or by potentiating the bodies’ own 
natural antioxidant defense systems (Fahn& Cohen, 1992; Metodiewa&Koska, 2003). This is 
supported by the findings that many herbal extracts and their components with 
neuroprotective activities exert both antiinflammatory and antioxidant effects at the same 
time (Ahlemeyer&Krieglstein, 2003; Kim et al., 1998; Oyama et al., 1996). One of the more 
useful Properties of flavonoids is their ability to prevent inflammation via their interaction, 
with various steps, along the eicosanoid pathway. 
For example, certain flavonoids, such as the flavones and hesperidin, in high concentrations, 
can directly inhibit the release of arachidonic acid from the cell membrane. Others, such as 
quercetin, Myricetin, kaempferol, naringenin, and hesperidin, can inhibit activation of 
phospholipase A2, which initiates the release of arachidonic acid from the 
cellmembrane.Certain flavonoids have been shown to either inhibit lipoxygenase (LPO) 
(hesperidin) or the cyclo-oxygenase-2COX)-2] enzymes, or even both (quercetin) (Lindah l& 
Tagesson, 1997). Pycnogenol is known to inhibit LPO, but not COX (Pietta, 1998).There is 
at least some evidence that prostaglandins can inhibit glutamate uptake, thereby increasing 
neurodegenerative excitotoxicity(Rohdewald, 1998).Knowing that Alzheimer’s patients have 
elevated levels of eicosanoids prostaglandin D2 (PGD2) and thromboxane-B2 (TXB2), it 
seems reasonable that flavonoids that inhibit the enzymes known to contribute to this 
abnormal rise in inflammatory substrates, should at least slow the progress of 
neurodegeneration or even prevent it. This appears to be the case in the clinical studies cited 
earlier in the text. 
vi.e. Flavonoids as Free Radical Scavengers 
The flavonoid compounds have two properties that make them especially useful as 
antioxidants. First, many are powerful, primary free radical scavengers against a wide variety 
of radicals, including singlet oxygen, superoxide, peroxyl, hydroxyl, and the peroxynitrite 
Chapter 1                                                                                         Introduction 
 
     Dept. of Pharmacology       24        J.K.K.Nattraja College of Pharmacy    
 
radicals. Second, several are known to be very effective metal chelators (Saija et al., 1995). 
Most flavonoids are present in plants as glycosides (Duthie et al., 1997). In the intestines, this 
moiety is cleaved-off, leaving the aglycone form of the flavonoid. It is the aglycone form that 
is thought to have the highest antioxidant activity in biological systems (Griffiths, 1982). 
 
There is experimental evidence that hydrogen peroxide accumulation occurs during the 
process of catecholamine catabolism, making it especially important in PD. Recent evidence 
also indicates that hydrogen peroxide (H2O2) plays an important role in the toxicity of 
Alzheimer’s plaques. As we have seen, iron accumulation within neurons is characteristic of 
ageing of the nervous system, but is especially high in the case of Neurodegeneration. A 
multitude of phytochemicals have specific properties that make them especially useful in 
combating neurodegeneration, and a list of nutrients that stimulate energy generation, 
primarily through the mitochondrial system are Coenzyme Q10, acetyl L-carnitine, α‑lipoic 
acid, vitamin K, nicotinamide, riboflavin, pyridoxine, folate/B12, thiamine and magnesium.  
 
 
 
 
vi.f. Nutraceuticals 
Nutraceutical, a portmanteau the words “nutrition” and “pharmaceutical”, is a food or food 
product that provides health and medical benefits, including the prevention and treatment of 
disease.Health Canada defines the term as, "A nutraceutical is a product isolated or purified 
from foods that is generally sold in medicinal forms not usually associated with food. A 
nutraceutical is demonstrated to have a physiological benefit or provide protection against 
chronic disease." 
 
Such products may range from isolated nutrients, dietary supplements and specific diets to 
genetically engineered foods, herbal products, and processed foods such as cereals, soups, 
and beverages 
 
With recent developments in cellular-level nutraceutical agents, researchers, and medical 
practitioners are developing templates for integrating and assessing information from clinical 
studies on complementary and alternative therapies into responsible medical practice.  
 
The term nutraceutical was originally defined by Dr. Stephen L. DeFelice, founder and 
chairman of the Foundation of Innovation Medicine (FIM), Crawford, New Jersey. Since the 
term was coined by Dr. DeFelice, its meaning has been modified by Health Canada which 
defines nutraceutical as a product isolated or purified from foods, and generally sold in 
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medicinal forms not usually associated with food and demonstrated to have a physiological 
benefit or provide protection against chronic disease. 
 
Examples: beta-carotene, lycopene. Nutraceutical foods are not subject to the same testing 
and regulations as pharmaceutical drugs. The following is an incomplete list of foods with 
reported medicinal value: 
• Antioxidants: resveratrol from red grape products; flavonoids inside citrus, tea, wine, 
and dark chocolate foods; anthocyanins found in berries  
• Reducing hypercholesterolemia: soluble dietary fiber products, such as psyllium seed 
husk  
• Cancer prevention: broccoli (sulforaphane), fiddleheads (Matteucciastruthiopteus)  
• Improved arterial health: soy or clover (isoflavonoids) 
• Lowered risk of cardiovascular disease: α- linolenic acid from flax or seeds. In 
addition, many botanical and herbal extracts such as ginseng, garlic oil, etc., have 
been developed as nutraceuticals. Nutraceuticals are often used in nutrient premixes 
or nutrient systems in the food and pharmaceutical industries. 
vi.g. Hesperidin 
Hesperidin is a flavonoid fount in the rinds of citrus fruits. Flavonoids are type of polyphenol, 
which are antioxidant that gives citrus fruit their color and Taste. It is also sold as a health 
supplement to repair and prevent cardiovascular disease   and also hesperidin is a flavonone 
glycoside fount in citrus fruits. Its name is derived from the word “hesperidium” for fruit 
produced by citrus trees. Hesperidin was first isolated in 1828 by French chemist from the 
white inner layer of citrus peels. Hesperidin is a plant chemical that is classified as a 
“bioflavonoid” and people use it is a medicine.Citrus fruits and their products are important 
sources of health-promoting constituents and are widely consumed around the world 
(Benavente& Castillo, 1997). Hesperidin is a naturally occurring flavonone that exists in 
citrus and other plants and can be isolated in large amounts from the peels of Citrus 
aurantium(bitter orange), Citrus sinensis(sweet orange), and Citrus unshiu(satsuma 
mandarin) (Crozier et al., 2009).Hesperidin is reported to exert a wide range of 
pharmacological effects such as antioxidant, antiinflammatory, antihypercholesterolemic and 
anticarcinogenic properties (Chen et al., 2010). It has also been demonstrated that hesperidin 
can protect neurons against various types of insults associated with many neurodegenerative 
diseases (Cho, 2006). 
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Hesperidin is a compound in orange peels that gives the flavonoid hesperidin to the body, and 
this flavonoid mediates most benefits of hesperidin including an Increase in circulation and 
possible brain protective effects. Hesperidin, alongsidearningenin, is known as the main 
citrus flavonoids. That being said, in animal studies oral intake of hesperidin at a dose similar 
to that used in humans seems to be a very potent cardioprotection agent and is quite 
protective of the brain in responseto variousstressors; the protection is antioxidative in nature, 
but it seems to work through a currently not identified antioxidant responses from the 
genome. Aside from the protective effects (most notable in the heart and brain, but extend to 
every organ), hesperidin may be able to reduce a lack of appetite and have minor anti-allergic 
properties.  
 
 
Hesperidin is also known as 5,7,3'-trihydroxy-4'-methoxyflavanone, hesperitin-7-O-
rutinoside, hesperitin glycoside, glucosyl hesperidin, vitamin P, hesperitin and G-hesperidin. 
Hesperidin can be found in (measured in aglycone equivalents, or in other words measuring 
hesperitin, unless otherwise specified): Commercial sweet orange (Citrus sinensis) 
juiceproducts in the range of 12.7-15.9 mg per 100 mL (Mazzaferro&Brecci, 2012) and 
around 15.25+/-8.21 mg per 100 g fresh fruit weight (Julia et al., 2006; Berhow, 1856). 
 
Our orange (Usually Citrus aurantium, also refers to bergamia and myrtifolia) tend to be high 
in flavanones at 47mg/100g fresh weight, although they tend to be neohesperidin and 
naringin (narirutin) rather than hesperidin (Julia et al., 2006) and contain barely any 
detectable hesperidin (at highest, 4.7µg/100g fruit weight) (Berhow, 1856; Russell et al., 
1987). Tangerines or 'Mandarin Oranges' (Citrus reticulata) at 19.26+/-11.56mg/100g fresh 
fruit weight (Julia et al., 2006; Berhow, 1856; Wilfred & Christ, 1997) and the sundried peel 
(known as Chenpi in Traditional chinese medicine, or as CitriReticulataePericarpum) contain 
hesperidin at 50-100 mg/g.Tangors, which are orange and tangerine hybrids, at 15.42+/-
7.00mg/100g fresh fruit weight (Julia et al., 2006; Berhow, 1856; Wilfred & Christ, 1997).  
Tangelos,which are tangerine hybrids with grapefruit (Citrus paradisi) or pumello (Citrus 
grandis) at 4.21+/-2.93 mg/100 g fresh fruit weight (these fruits are highest in neohesperidin) 
(Julia et al., 2006; Berhow, 1856; Russell et al, 1987). The peels of tangerines, however, 
appear to have 5-10% of their weight as hesperidin after 5-7 Days of drying (to remove water 
content and concentrate the hesperidin) and as such a 500 mg supplemental dose of 
hesperidin can be achieved by 5-10 g of the dried tangerine peel. This is a low cost alternate 
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assuming that the peel is thoroughly scrubbed prior to drying to remove possible 
contamination and grime collected on the peel. 
 
vi.h. Antioxidant Properties of Hesperidin 
The antioxidant hesperidin, a major flavonoid in sweet orange and lemon, was evaluated 
using chemical and biological systems hesperidin treated with stressing agent’s hydrogen 
peroxide or paraquat. Hesperidin was able to reduce significantly the level of the free radical 
DPPH· with similar efficacy of trolox (positive control (Patricia et al., 2005) When the yeast 
cells were exposed to the flavonoid hesperidin before the stressing agents, there was a 
significant increase in the survival of all strains. Paraquat induced higher catalase and 
superoxide dismutase than did H2O2, which only increased catalase activity. Previous 
addition of hesperidin to these treatments was able to reduce significantly both enzymatic 
levels. These observations clearly demonstrate that hesperidin provides strong cellular 
antioxidant protection against the damaging effects induced by paraquat and peroxide 
hydrogen.  Antioxidants are vital substances that protect the body from damage caused by 
free radical-induced oxidative stress. 
 
Free radicals can be generated from metabolic pathways within body tissues and can also be 
introduced from external sources such as drugs, food, UV radiation and environmental 
pollution (Jungsook, 2006). Free radicals have been implicated in the cause of several 
diseases such as liver cirrhosis, atherosclerosis, cancer and diabetes and play an important 
role in ageing. Oxidative stress can also contribute to the development of neurodegenerative 
disorders, such as AD and PD as well as other diseases.  
 
These free radicals attack unsaturated fatty acids of biomembranes, resulting in lipid 
peroxidation and desaturation of proteins and DNA, causing a series of deteriorative changes 
in thebiological systems leading to cell inactivation. Thus, antioxidants are important 
inhibitors of lipid peroxidation, not only for food protection but also in defending living cells 
against oxidative damage. Lipid peroxidation is an important deteriorating reaction in food 
during storage and processing that causes a loss in nutritional quality. 
 
The addition of antioxidants is required to preserve food quality. Antioxidant supplements 
orantioxidant-rich food is used to help the human body reduce Oxidative damage from Free 
radicals and active oxygen species. Another synthetic antioxidants such as butylated hydroxyl 
toluene (BHT),butylated hydroxyl anisole (BHA) and trolox are widely used as antioxidants 
in the pharmaceutical and food industry. However, they have been shown to have toxic 
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and/or mutagenic effects. Because of their toxicity, the development and isolation of natural 
antioxidants from plant species, especially edible plants, such as silymarin, polyphenols and 
flavonoids are in progress. 
 
In vitro investigations have demonstrated that the antioxidant properties of flavonoids are 
linked with their capability for scavenging free radicals, chelating metals and inhibiting the 
activity of oxidases. Flavonoids are family of polyphenolic compounds found in fruits and 
vegetables. Flavonoids have wide biological properties including antibacterial, antiviral, 
anticancer, immune stimulant and antioxidant Effects. Flavonoids activity as antioxidants 
refers to their ability to transfer a hydrogen atom or an electron and to the possibility of their 
interactions with other antioxidants. Hesperidin is a flavonone glycoside, belonging to the 
flavonoid family. This natural product is found in citrus species. Hesperidin was reported to 
have many biological effects including antiinflammatory, antimicrobial, anticarcinogenic and 
antioxidant effects, and decreasing capillary fragility. 
 
The flavonoid hesperidin may serve as a hydrogen donor for α-tocopherol radical, thus 
regenerating α-tocopherol, a key element of redox balance in biosystems. Hesperidin, in 
combination with a flavone called diosmin is used asDaflon®(Servier, France) to treat 
chronic venous insufficiency in Europe. Other biological effects of hesperidin are 
unknown.However, the structural activity relationship of hesperidin on their antioxidative 
activity has not been fully reported. In the present study, the structural activity effects of 
hesperidin on the antioxidative activities were investigated using a simple free radical 
scavenging system including, reducing power, Chelating activity on Fe2+, free radical 
scavenging, total antioxidant, superoxide radical scavenging, Hydrogen peroxide scavenging 
and hydroxyl radical scavenging activities in an attempt to understand its mechanism of 
action, which may pave the way for possible therapeutic applications. 
 
Hesperidin has high antioxidant property. The antioxidant activity was evaluated using 
chemical and biological systems. The chemical assay evaluates the hesperidin capacity to 
sequester 1,1-diphenyl-2-picrylhydrazyl (DPPH·). Biological Studies were done using the 
eukaryotic cells of superoxide-dismutase proficient and deficient Strains of Saccharomyces 
cerevisiae treated with hesperidin and the stressing agents hydrogen peroxide or paraquat 
(methylviologen; 1,1‘-dimethyl-4,4‘-bipyridinium dichloride). Hesperidin was able to reduce 
significantly the level of the free radical DPPH· with similar efficacy of trolox (positive 
control). When the yeast cells were exposed to the flavonoid hesperidin before the stressing 
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agents, there was a significant increase in the survival of all strains. Paraquat induced higher 
catalase and superoxide dismutase than did hydrogen peroxide, which only increased catalase 
activity. Previous addition of hesperidin to these treatments was able to reduce significantly 
both enzymatic levels. These observations clearly demonstrate that hesperidin provides 
strong cellular antioxidant protection against the damaging effects induced by paraquat and 
peroxide hydrogen (Patricia et al., 2005).despite many reports on the medicinal or functional 
properties of hesperidin, substantial papers have not been published on the role of hesperidin 
in multiple organ failure/dysfunction. Therefore, in an effort to contribute further to the 
knowledge of hesperidin and on its traditional use, as a raw constituent of plants rich in 
hesperidin, and its sacred and rich history, the objective of the present study is designed to 
evaluate the possible role in protection against LPS induced neurodegeneration. 
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2. REVIEW OF LITERATURE 
II.a. Lipopolysaccharide 
Lipopolysaccharide (LPS), a major constituent of the outer membrane of gram-negative 
bacteria and is a key molecule in the pathogenesis of gram-negative endotoxemia, responsible 
for hemodynamic, hematological and metabolic changes, sepsis and septic shock (Bone, 
1991). It is a large molecule, consisting of a polysaccharide attached to a lipid component, 
named lipid-A (Figure 2). The polysaccharide component consists of a core and a polymer of 
oligosaccharide molecules (O-antigens), which is immensely variable and specific to each 
bacterial strain. The polysaccharide core is bound to lipid-A through a specific sugar called 2-
keto-3-deoxyoctulosonic acid (KDO) (Rietschel, 1982). Lipid-A is a peculiar bacterial lipid 
consisting of a phosphorylated β-1, 6-linked glucosamine disaccharide, to which long fatty 
acids are attached and is assumed to be responsible for the induction of expression of 
cytokines by LPS, although KDO and the polysaccharide component probably potentiate its 
activity (Haeffner-Cavaillonet al., 1989; Rietschelet al., 1987).  
LPS function has been under experimental research for several years due to its role in 
activating many transcription factors, which become active after stimulation with LPS. LPS 
also produces many types of mediators involved in septic shock. It has become evident that 
there are diverse triggers like immunological insult, such as LPS; environmental toxins; 
endogenous disease proteins; neuronal injury; through which microglia are activated to exert 
their neurotoxicity. LPS-induced prototypical gram-negative endotoxemia is accompanied by 
contact system activation, complement activation, production of cytokines and other evidence 
of unregulated inflammatory responses (Bone, 1996; Deitch, 1998).  
LPS induce inflammatory responses and parenchymal toxicity in liver diseases. LPS from P. 
acnes causes extensive liver injury mimicking fulminant hepatitis (Ferluga& Allison, 1978). 
Liver injury and massive hepatocellular damage can be also induced by a low dose of LPS in 
animals (Hirokazu et al., 1999).LPS exerts its effects by stimulating inflammatory cells and 
hepatic Kupffer cells to produce various pro-inflammatory cytokines, including tumour 
necrosis factor- alpha (TNF-a), interleukin-1 (IL-1), interleukin-6 (IL-6), interleukin-12 (IL-
12) and interferon-gamma (IFN-g). It induces activation of caspases and apoptosis in 
hepatocytes prior to secondary necrosis and release of transaminases by activation of TNF 
receptor-1 (Batey& Wang, 2000; Malhi& Gores, 2008). The hepatic sinusoidal cells, 
particularly the fixed macrophages (Kupffer cells), are critical to normal endotoxin 
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detoxification. The initial damage in a number of injuries is to sinusoidal cells, which 
seriously impacts the ability of the liver to handle the ordinarily innocuous amounts of LPS 
coming from the gut. This marked increase in sensitivity to LPS, which may be of a 
magnitude of 10-fold to 1000-fold, leads to further hepatocytic damage and spill over of the 
endotoxins into the systemic circulation, resulting in the extrahepatic manifestations 
associated with liver injury (James PN, 2010). 
The interaction between Kupffer cells, endotoxins, and hepatic injury remains a major area for 
productive investigation. It has long been known that liver endocytosis by Kupffer cells are a 
major phagocytic activity that removes many antigens from the portal and general circulation, 
including foreign particulate matter, immune complexes, and gut-derived endotoxin. There 
expected toxic hepatic and extrahepatic effects of endotoxin after liver injury (James, 1975). 
LPS is known to induce SIRS condition in animal models and widely exploited for the search 
for mechanisms of SIRS-related conditions and exploration of drug development. LPS was 
shown to cause experimentally SIRS with acute renal failure. LPS induced a significant renal 
insufficiency as denoted by increase in plasma blood urea nitrogen (Remick et al., 2000; 
Hollenberg et al., 2000). 
The administration of LPS to animals reproduces most of the clinical features of sepsis, 
including AKI, a condition associated with renal cellular dysfunction and apoptosis 
(Stoyanoff et al., 2014). Acute renal failure as a consequence of septicemia by LPS may be 
due to a decrease in glomerular blood pressure and renal blood flow, but it has been 
demonstrated in animal models that even in the absence of a reduction in blood pressure, LPS 
induces renal injury. There are studies to confirm that LPS cause marked renal damage, as 
demonstrated by an increase in plasma BUN. This was accompanied by a significant decrease 
in the vitamin E content of renal tissue and plasma (Kadkhodaee&Qasemi, 2004).  
Administration of LPS to humans or laboratory animals induces a variety of physiological 
responses, neuroendocrine changes (Bluthé et al., 1992; Dunn, 1992) and modifications of 
behavior consisting of fever (Kluger, 1991; Kozak et al., 1994), anorexia and body weight 
loss, anhedonia, suppression of locomotor and exploratory activity and reduced social 
behavior (Yirmiya et al., 1994; Yirmiya, 1996) sleepiness, depression (sickness behavior) 
(Bluthé et al., 1992; Hart, 1988). Thus it has been suggested that immunological activation 
with LPS or cytokines themselves and may be interpreted by the CNS as a stressor, and that 
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the immune system may act as a sensory organ for non-cognitive stimuli such as bacteria, 
tumors, viruses etc, (Anisman&Merali, 2002; Shen et al., 1999; Dunn & Vickers, 1994). 
It is well established that brain tissue is susceptible to degeneration in response to insult such as 
oxidative stress or infection. Peripheral administration of LPS initiates a robust inflammatory 
response, which is mediated by pro-inflammatory cytokine and free radical generation (Feng et 
al., 1995). 
II.b. LPS: Oxidative Stress and Inflammation 
Liver injury and dysfunction are typical features of the multiple organ failure complicating 
clinical gram-negative septic shock (Ring &Stremmel, 2000). The data presented here support 
a possible role of flagellin as an initiator of such abnormalities. Indeed, flagellin 
administration was associated with the occurrence of liver damage, indicated by an increase 
in plasma aminotransferases, significantly more pronounced than after LPS. While a possible 
mechanism underlying this effect was the marked oxidant stress generated by flagellin, 
additional studies, both morphological and functional, are required to more precisely define 
the mechanisms of flagellin toxicity on this organ (Lucas et al., 2002). 
Within the liver, the LPS binds to LPS binding proteins which then facilitate its transfer to 
CD14 receptors on the surface of Kupffer cells, the resident macrophages of liver. Signalling 
of LPS through CD14 receptors is mediated by the downstream Toll-like receptor-4 and 
results in the production of two classes of potentially disastrous mediators: proinflammatory 
cytokines such as interleukins (IL-1, IL-6), tumour necrosis factor (TNF)-α and oxygen free 
radicals (Luster et al., 1994). Most of the toxicities of LPS, both in the liver and in the 
systemic circulation, have been related to the release of these toxic mediators 
(Hartung&Wendel, 1991). LPS-induced increase in lipid peroxidation, which is an index of 
oxidative stress, has been described in several studies and is, reported to be both time- and 
dose-dependent. Lipid peroxidation was enhanced in rats as early as 45 min post-LPS 
infusion [100 mg/kg body weight (b.w.)] in many tissues including the liver, small intestine, 
stomach and abdominal aorta (Yoshikawa et al., 1994). Hepatic levels of malonaldehyde 
(MDA, a product of lipid peroxidation) increased fivefold within 16 h after LPS 
administration (15 mg/kg b.w.) and 3·4-fold 8 h after 30 mg/kg LPS administration (Sugino et 
al., 1987). Several studies have shown that LPS can cause liver glutathione (GSH) depletion 
in a dose-dependent manner (Jaeschke et al., 1993). This is thought to be secondary to 
enhanced efflux of GSH from the liver or acute depression of liver GSH synthesis. Also 
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oxidized glutathione (GSSG) is released from liver and other tissues during oxidative damage 
(Kaur et al., 2006).  
Figure 1. Structure of Lipopolysaccharide from Different Bacterial Species 
  Species   A  B C D R1 R2    R3 
 E.coli    14  14 14 14 14:0 12:0     H 
 Salmonella spp   14  14 14 14 14 12:0     14 
 P.gigivatis*   15  17 16 17 H 16:0     H 
 N.Meningitidis   12  14 12 14 H 12:0     12:0 
 R.sphaoroidos   10 12 10 12 H cis4512:1   H 
*No phosphate e group on position 4’ of the non-reducing glucosamine; ethanolamine at the other Phosphate group. 
III. a. Plant Phenolics as Nutraceuticals 
Flavonoids are a group of low molecular weight polyphenolic compounds of plant origin, 
many of which alter metabolic processes and have a positive impact on health (Beecher, 
2003). They exhibit a variety of biological activities such as anti-inflammatory, antioxidant, 
antiviral and antitumor (Middleton et al., 2000; Middleton & Kandaswami, 1992). 
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Epidemiological studies have suggested positive associations between the consumption of 
phenolic-rich foods or beverages and the prevention of diseases (Scalbert & Williamson, 
2000). These effects have been attributed to antioxidant components such as plant phenolics, 
flavonoids and phenyl propanoids among others (Rice-Evans et al., 2004). 
III. b. Hesperidin 
i. Sources 
Hesperidin is a flavanone glycoside named after the term 'Hesperidium', referring to citrus 
fruits which are the main source of hesperidin. Hesperidin and its aglycone are common 
dietary flavonoids due to being large compounds of citrus fruits (alongside naringenin) and 
especially the peels and pericarp (Katherine et al, 1993) hesperidin has once been noted to 
comprise up to half of the flavonoid intake of Finland in surveys due to its prominence in the 
diet (at 28.3mg daily calculated as aglycones) (Knekt et al., 2002) and it could be argued that 
it is a Traditional Chinese Medicine (perhaps alongside naringenin) since the dried peels of 
citrus have been used medicinally and referred to as Chimpi (Ito et al., 2013). 
A classical term 'Citrin' or 'Vitamin P' is used to refer to a mixture of Hesperidin and 
Eriodictoyl (another flavonoid), which were initially thought to have vitamin-like properties 
by having wound healing properties and treating scurvy; this was later attributed to Vitamin 
C (Harold, 1940; Garg et al., 2001).  
ii. Some other sources that are not in the citrus family 
 Boehmerianivea (of the Urticaceae family) at 23.69 mg/100g (Sung et al., 2013). 
Valerianawallichii (of the family Valerianaceae) at 6.2+/-0.25mg/g (0.6%) of a water 
extract (Katoch et al., 2012). 
 Cyclopiasubternata (Honey bush) at 0.504+/-0.495mg/g (range of 0.147–1.517mg/g) 
in the leaves and 1.559+/-0.289mg/g (range of 1.164–1.893mg/g) in the stems (De 
Beers et al., 2012; Petrova et al., 2011). 
 Codonopsispilosula (Qi et al., 2011) 
 Schizonepetatenuifolia (Sohn et al., 2012) at 12.0+/-0.4mg/g dried leaves (Wang et 
al., 2012).  
 Byrsonimacrassifolia (of the family malpighiaceae) at 0.7mg/kg dry weight (Herrera-
Ruiz et al., 2011). 
Hesperidin, a flavanone-type flavonoid, is found abundant in the peel and membranous parts 
of citrus fruit (Williamson, 1972). Hesperidin is comprised of the flavanonehesperitin and the 
disaccharide rutinose and has been reported to have many biologically important properties, 
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including anti-inflammatory, antimicrobial, anticarcinogenic, antioxidant and capillary 
strengthening effects (Garg et al., 2001). Hesperidin has also been reported to possess anti 
hypercholesterolemic activity (Son et al., 1991), anti-inflammatory and analgesic activity 
(Galati et al., 1994), antifungal activity (Krolicki et al., 1984) and anticarcinogenic activity 
(Yang et al., 1997). The antioxidant activity and radical scavenging properties of hesperidin 
have been analyzed and reported by several investigators using a variety of assay systems 
(Deng et al., 1997; Miller et al., 1997; Suarez et al., 1998, Malterud et al., 2000). Further, 
hesperidin was found to be effective in protecting liposomes from UV-irradiation induced 
peroxidation, probably by scavenging the oxygen free radicals generated by UV-irradiation 
(Bonina et al., 1996). 
Hesperidin, a flavanone glycoside copiously found in sweet orange and lemon, is an 
inexpensive by-product of citrus cultivation (Garg et al., 2001). Hesperidin is effectively 
used as a supplemental agent and helps to reduce edema or excess swelling in the legs due to 
fluid accumulation. It has been reported to possess significant anti-inflammatory, analgesic, 
antifungal, antiviral antioxidant, and anticancer activities (Galati et al., 1994; 
Wacker&Eilmes, 1975). A number of researchers have documented the antioxidant activity 
and radical scavenging properties of hesperidin (Fraga et al., 1987; Jovanovic et al., 1994; 
Miller & Rice-Evans, 1997; Vaibhav& Kumar, 2010).  
Hesperidin was first isolated in 1828 by French chemist Lebreton from the white inner layer 
of citrus peels. Hesperidin is a compound in orange peels that gives the 
flavonoid hesperitin to the body, and this flavonoid mediates most benefits of hesperidin 
including an increase in circulation and possible brain protective effects. Hesperidin, 
alongside naringenin, is known as the main citrus flavonoids. 
Hesperidin, a bioflavonoid, is an abundant and inexpensive by-product of Citrus cultivation. 
A deficiency of this substance in the diet has been linked with abnormal capillary leakiness as 
well as pain in the extremities causing aches, weakness and night leg cramps. No signs of 
toxicity have been observed with the normal intake of hesperidin or related compounds. 
Both hesperidin and its aglyconehesperitin have been reported to possess a wide range of 
pharmacological properties. This paper reviews various aspects of hesperidin and its related 
compounds, including their occurrence, physical and chemical properties, analysis, 
pharmacokinetics, safety and toxicity and the marketed products available. A special 
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emphasis has been laid on the pharmacological properties and medicinal uses of these 
compounds. However, the mechanisms of action are still unclear (Garg et al., 2001) 
 
iii. Structure 
As a glycoside (with sugars), it has an aglycone (without sugars) flavanone known as 
hesperitin (5,7,3'-trihydroxy-4'-methoxyflavanone) and can also be referred to chemically as 
hesperitin-7-O-rutinoside (as the sugar it is bound to is rutinose) or hesperitin-7-O-
rhamnosyl(1-6)glucoside (since a 'rutinose' sugar is 6-O-α-L-rhamnosyl-D-glucose, or simply 
a rhamnose sugar bound to a glucose). 
 
The main molecule here is hesperitin, but it is found in foods as hesperidin which pretty 
much acts like a hesperitinprodrug (gives the body hesperitin, but is better than hesperitin 
itself at doing so due to various reasons). G-Hesperidin is another synthetic prodrug for 
hesperitin. Hesperidin is known as a flavanone (a subset of flavonoid or bioflavonoid) due to 
there not being a double bond between the 2 and 3 carbon on the A ring, which is the 
rightmost vertical line one the middle hexagon (a double bond would mean that two vertical 
lines were there). This lack of a double bond means that the B ring (hexagon not immediately 
bonded to another, furthest right on the pictures below) is more perpendicular to the other two 
rather than adjacent like shown in the 'standard depiction'. 
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iv. Traditional Claims of Hesperidin 
 Internal hemorrhoids, when used in combination with diosmin. The combination of 
hesperidin and diosmin seems to both significantly improve symptoms of 
hemorrhoids and also keep hemorrhoids, once healed, from coming back. 
 Treating leg ulcers caused by poor circulation, when used in combination with 
diosmin. Hesperidin, in combination with diosmin and a compression dressing, seems 
to improve healing of small ulcers (less than 10 cm) caused by poor blood circulation. 
 Reducing arm swelling in lymphedema following surgery for breast cancer. 
 Varicose veins and improves circulation 
v. Health Benefits of Hesperidin  
 Hesperidin has antioxidant, anti-inflammatory, hypolipidemic, vasoprotective and 
anticarcinogenic and cholesterol lowering actions. Hesperidin can inhibit following 
enzymes: phospholipase A2, lipoxygenase, HMG-CoA reductase and cyclo-
oxygenase. 
 Hesperidin improves the health of capillaries by reducing the capillary permeability. 
 Hesperidin is used to reduce hay fever and other allergic conditions by inhibiting the 
release of histamine from mast cells. The possible anti-cancer activity of hesperidin 
could be explained by the inhibition of polyamine synthesis. 
 A study 'hesperidin, a citrus flavonoids, inhibits bone loss and decreases serum and 
hepatic lipids in ovariectomized mice' by Hiroshige Chiba et al., 2003 showed that 
hesperidin added to the died not only lowered serum and hepatic cholesterol, but also 
inhibited bone loss by decreasing osteoclast number in ovariectomized mice. The 
molecular mechanism of the inhibitory effect of hesperidin on bone resorption is not 
clear. 
  
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III. c. Literature Review of Hesperidin 
i. Antioxidant Properties of Hesperidin 
Hesperidin possesses general protective effects against oxidative liver toxins, which are 
currently thought to be related to its antioxidant properties. Antioxidant enzymes such as 
SOD, catalase, and glutathione peroxidase seem to be fully preserved relative to control rats 
in groups administered with hesperidin (Balakrishnan&Menon, 2007). 50µM hesperitin was 
also neuroprotective against H2O2, but this was due to direct antioxidant properties and is not 
thought to be relevant to oral supplementation of hesperidin as it is too high a concentration 
(Hwang & Yen, 2011). There appear to be antioxidant effects in the brain where hesperidin 
reduces the increase in lipid peroxidation during cognitive damage, but this appears to be 
indirect through nitric oxide signaling (inhibition) rather than a direct antioxidant 
effect.Hesperidin at 100mg/kg orally to young and old rats for 90 days is able to partially 
reverse the worsening of antioxidant enzymes seen in heart tissue with aging, while the 
changes to these enzymes in young hearts were not significant (Elavarasan et al., 2012). 
Hesperidin was able to reduce significantly the level of the free radical DPPH· with similar 
efficacy of trolox (positive control) when tested with yeast cells that are exposed to paraquat 
(Patricia et al., 2005) 
ii. Anti-inflammatory Properties of Hesperidin 
Hesperidin is thought to have anti-inflammatory properties in fat cells, and while this 
technically does occur it happens at rather larger concentrations and has not yet been 
confirmed in a living model. Hesperidin significantly protects microglia activation and 
reduces the release of inflammatory cytokines proving the anti-inflammatory effect of 
hesperidin (Kuppusamy et al., 2013). 
iii. Longevity 
In a screening process in yeast for longevity promoting flavonoids, it was found that 
hesperidin was able to increase activity of the sir2 gene (human homologue is SIRT1) and 
superoxide dismutase (SOD) resulting in less reactive oxygen species production; these 
benefits were not seen with the aglyconehesperitin (Sun et al., 2012). 
Elsewhere, hesperidin (and rutin; the rhamnoside of Quercetin) have been noted to increase 
neural crest cell viability (neural progenitor cells) with peak efficacy at 20µM; the potency 
being comparable between both rhamnosides and not present with quercetin, implicating the 
rhamnoside group itself (Nones et al., 2012).  
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Hesperidin is an essential bioflavonoid and accessory nutrient to form a Vitamin C Complex 
with rutin (previously known as Vitamin P factor). They function synergistically with 
Vitamin C in regard to maintaining healthy capillaries, to help form collagen in connective 
tissue, to help heal wounds, and to support a healthy immune system. Rutin and/or 
hesperidin, when low, frequently result in predictable, and even side-specific medical 
problems that include a greater risk for vascular degeneration, bruising / capillary fragility, 
nose bleeds, varicose veins, periodontal bleeding, hemorrhoids and aneurism, with few 
individuals exhibiting optimal levels, despite mega-supplementation. One reason is the 
chemical interaction of other nutrients with flavonoids which can have a synergistic or 
inhibiting effect. Various drugs also interact with bioflavonoids and affect their efficacy. 
 
iv. Neurology 
Hesperidin was found not to possess any significant influence on dopaminergic, adrenergic, 
serotonergic transmissions in CNS. No known interactions with dopamine metabolism in the 
brain following hesperidin/hesperitin interventions. 
v. Nitrergic Neurotransmission 
50-100 mg/kg hesperidin orally for two weeks prior to an immobilization stress test was able to 
exert neuroprotective effects in a manner inhibited by Nitric Oxide donors (L-arginine) and 
potentiated by NOS inhibitors,suggesting negative regulation of nitric oxide signaling in the 
protective effects of hesperidin. 
vi. Memory and Learning  
In a model of memory dysfunction associated with ischemic stroke, supplementation of 
hesperidin (50-100 mg/kg oral for a week prior to ischemia) is able to minorly attenuate the 
memory loss seen in an elevated maze plus test in a manner that is associated with 
suppressing excessive nitric oxide signaling. The magnitude of memory loss (assuming that 
control was 100% reduction) was reduced to around a 20-60% reduction in a dose-dependent 
response, with neither dose normalizing to undamaged control (Vaibhav& Kumar, 2010). 
vii. Depression 
Injections of 0.1-1 mg/kg hesperidin (intraperitoneal) to mice subject to a force swim test is 
able to exert antidepressant effects while 10 µg/kg was ineffective on its own (Filho et al., 
2013) and this has been replicated elsewhere in forced swim and tail suspension tests with a 
potency comparable to imipramine (15 mg/kg injection) and fluoxetine (32 mg/kg injection) 
at the dose of 0.3-1mg/kg (Souza et al., 2013). 
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viii. Anxiety and Stress 
In a study which found antidepressant effects with intraperitoneal injections of hesperidin 
(0.1-1mg/kg), there was no apparent anxiolytic effect (Filho et al., 2013) and this lack of 
effect has been noted elsewhere with oral ingestion of 20-100 mg/kg hesperidin. Anxiolytic 
effects can be forced with high doses of hesperidin injections (2-30 mg/kg) in mice, thought 
to be related to the opioidergicsignalling (Souza et al., 2013; Loscalzo et al., 2011). 
ix. Sedation and Sleep 
Hesperidin has been described as a sedative flavanone(Martinez et al., 2009) possibly due to 
injections of hesperidin having suppressive effects in rodent locomotor tests (Wasowski et al., 
2012; Martinez et al., 2009; Loscalzo et al., 2011) with an ED50 of 11.34+/-2.48 mg/kg 
(Guzmán-Gutiérrez &Navarrete, 2009) possible related to its opioidergicsignalling (via the 
µ-opioid receptor) (Loscalzo, 2011). This does not occur with oral ingestion of hesperidin in 
the range of 20-100 mg/kg, possibly because orally ingested hesperidin is metabolized to 
hesperitin and the aglycone (hesperitin) does not possess this opioidergic activity (Wasowski 
et al., 2012). Injections may be synergistic with benzodiazepines (GABAA receptor agonists) 
as well, but this may not extend to oral intake (Loscalzo et al., 2011). 
That being said, oral ingestion of hesperidin has been noted to signal in a manner dependent 
on κ-opioid receptors (Filho et al., 2013) and pharmaceutical κ-opioid agonists have been 
noted to have weak sedative effects. It is not known if oral supplementation of hesperidin 
confers sedative effects at higher doses (Tsukahara-Ohsumi et al., 2011). 
x. Appetite and Food Intake 
Ghrelin administration is known to enhance food intake (Neary et al., 2004) possible 
secondary to growth hormone secretion (Laferrère et al., 2005) and a Kampo formulation 
known as Rikkunshito is known to stimulate Ghrelin secretion (Takeda et al., 2008; 
Matsumura et al., 2010) via antagonism of the serotonergic 5-HT2B/2C receptors; in 
Rikkunshito, hesperidin is thought to be active (Takeda et al., 2008). 
Hesperidin by itself at 5mg/kg orally to rats (where anorexia was induced by cisplatin) 
appears to attenuate the reduction in food intake seen with cisplatin by 59% while as a 
potency comparable to 1,000 mg/kg Rikkunshito but lesser than the synthetic 5-HT2C 
receptor antagonist SB242084HCl (full negation), and the attenuation of anorexia seen with 
all of the three aforementioned was prevented with a GHS-R1a (Growth hormone 
secretagogue receptor) antagonist (Yakabi et al., 2010), which is the receptor that Ghrelin acts 
upon (Wellman et al., 2013).  
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xi. Cardiovascular Health 
Cardiac Tissue 
Hesperidin at 100 mg/kg orally to young and old rats for 90 days is able to partially reverse 
the worsening of antioxidant enzymes seen in heart tissue with aging, while the changes to 
these enzymes in young hearts were not significant; a decrease in lipid peroxidation and 
protein carbonylation, and this was thought to be due to an increase in Nrf2 expression seen 
in the aged hearts that was decreased with aging (there was no increase in youth) (Elavarasan 
et al., 2012).  
Blood Flow 
In isolated endothelial cells, 1-10µM hesperidin has been noted to phosphorylated Ser1179 
which resulted in its increased activity, (Rizza et al., 2011) which is thought to be due to 
phosphorylation from AMPK (Chen et al., 1999) or Akt (Dimmeler et al., 1999) on eNOS 
since both of those proteins were activated from hesperidin (Rizza et al., 2011). Blocking 
either protein resulted in attenuation of eNOS activation from hesperidin and preventing ROS 
formation (with incubations of N-Acetylcysteine) blocked the effects, and similar to EGCG 
from Green Tea Catechins (Kim et al., 2007) it was attributed to thSrc protein known as Fyn 
(which acts on PI3K to then influence the two proteins, and is stimulated by the radical H2O2 
(Griffin et al., 2000) where the hydroxyl groups have been noted to be critical to production 
of H2O2 from EGCG (Auger et al., 2010) and are thought to be the same for hesperidin (Rizza 
et al., 2011).  
Hesperidin has also been tested at a slightly higher concentration of 12.5µM in HUVEC cells, 
and the increase in nitric oxide production was significantly attenuated with estrogen blockers 
(Liu et al., 2008) hesperidin also increased eNOS transcription at 50µM, but these effects 
were not observed with naringenin (which was also estrogenic) while being observed with 
10nM 17β-estradiol (Liu et al., 2008). Estrogen signalling via the alpha subset (ERα) 
(Muller-Delp et al., 2003) is also involved in producing nitric oxide (via increasing eNOS 
phosphorylation at Ser1179 (Chambliss et al., 2000) secondary to Src signalling, where Fyn 
is implicated by c-Src is more important (Haynes et al., 2003), which suggests that estrogenic 
signalling may underlie the observed benefits. 
Hypolipidemic Activity 
Hesperidin, the most important flavanone of Citrus sp., significantly increases HDL and 
lowerscholesterol, LDL, total lipid and triglyceride plasma levels in normolipidemic rats and 
in rats with diet- and triton-induced hyperlipidemia. 
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Cholesterol 
G-hesperidin has been noted to suppress the secretion of Apolipoprotein B from HepG2 
(liver) cells mildly at concentrations of 100µM and above when co-incubated; this may be 
due to donating hesperidin since it was active to the same degree at 25-50µM, and it appeared 
that the overall production of apolipoprotein B was reduced to a comparable level as the 
reduction in secretion (Miwa et al., 2006) This reduction of Apolipopotein B has been noted 
in vivo with 500mg of G-Hesperidin (Miwa et al., 2005). 
Anti-Hypertensive 
Hesperidin (LIES) is a flavonoid contained in citrus fruit peel. We investigated the effects of 
long-term administration of HES and its newly developed water soluble analogue, glucosyl 
hesperidin (GHES), to spontaneously hypertensive rats (SHR) and normotensive Wistar-
Kyoto rats (WKY). Animals were fed with diets containing HES or GHES (30 mg/d/kg body 
weight) for 25 wk. While the daily food intake and the body weight of administered rats were 
not different from those of the non-administered control rats in both SHR and WKY through 
the experimental period, the blood pressure and heart rate of SHR administered HES or 
GHES for longer than 15 wk decreased as compared to the control group. The blood pressure 
and heart rate of WKY were not changed by the long-term administration of HES or CHES. 
These results suggest that HES and GHES have anti-hypertensive effects on hypertensive 
animals. 
Anti-Coagulant 
Two flavonoids, rutin and hesperidin, were investigated in vitro for anticoagulant activity 
through coagulation tests: activated partial thromboplastin time (aPTT), prothrombin time 
(PT) and thrombin time (TT). Only an ethanolic solution of rutin at the concentration of 830 
µM prolonged aPTT, while TT and PT were unaffected. In order to evaluate whether the 
prolongation of a PTT was due to the decrease of coagulation factors, the experiment with 
deficient plasma was performed, showing the effects on factors VIII and IX. Since 
pharmacological activity of flavonoids is believed to increase when they are coordinated with 
metal ions, complexes of these flavonoids with Al(III) and Cu(II) ions were also tested. The 
results showed that complexes significantly prolonged aPTT and had no effects on PT and 
TT. Assay with deficient plasma (plasma having the investigated factor at less than 1%) 
revealed that complexes could bind to the coagulation factors, what may lead to a non-
specific inhibition and aPTT prolongation. An effort was made to correlate stability of 
complexes with their anticoagulant properties. 
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Vasorelaxant Activity, Superoxide-Scavenging Ability and Cyclic Nucleotide 
Phosphodiesterase-Inhibitory Effects 
This study investigated the vasorelaxant activity, superoxide radicals (O2 •−)-scavenging 
capacity and cyclic nucleotide phosphodiesterase (PDE)-inhibitory effects of hesperidin and 
hesperetin, two flavonoids mainly isolated from citrus fruits. Hesperetin concentration-
dependently relaxed the isometric contractions induced by noradrenaline or by a high 
extracellular KCl concentration (60 mM) in intact rat isolated thoracic aorta rings. However, 
hesperetin did not affect the contractile response induced by okadaic acid. Hesperetin did not 
scavenge O2 •− generated by the phenazinemethosulfate (PMS)-reduced β-nicotinamide 
adenine dinucleotide (NADH) system. Hesperetin significantly reversed the inhibitory effects 
ofNA and high KCl on cyclic nucleotide (cAMP and cGMP) production in cultured rat aortic 
myocytes. Hesperetin preferentially inhibited calmodulin (CaM)-activated PDE1 and PDE4 
isolated from bovine aorta with IC50 values of about 74 µM and 70 µM respectively. In 
contrast, the 7-rhamnoglucoside of hesperetin, hesperidin, was inactive in practically all 
experiments, although it inhibited basal and cGMP-activated PDE2 isolated from platelets 
(IC50 values of 32±4 µM and 137±34 µM respectively). These results suggest that the 
vasorelaxant effects of hesperetin are basically due to the inhibition of PDE1 and PDE4 
activities. 
x. Bone 
The purpose of this study was to examine whether hesperidin inhibits bone loss in 
ovariectomized mice (OVX), an animal model of postmenopausal osteoporosis. Forty 8-wk-
old female ddY mice were assigned to five groups: a sham-operated group fed the control 
diet (AIN-93G), an OVX group fed the control diet, an OVX+HesA group fed the control 
diet containing 0.5 g/100 g hesperidin, and an OVX+HesB group fed the control diet 
containing 0.7 g/100 g α-glucosylhesperidin and an OVX+17β-estradiol (E2) group fed the 
control diet and administered 0.03 µg E2/d with a mini-osmotic pump. After 4 wk, the mice 
were killed and blood, femoral, uterine and liver were sampled immediately. Hesperidin 
administration did not affect the uterine weight. In OVX mice, the bone mineral density of 
the femur was lower than in the sham group (P< 0.05) and this bone loss was significantly 
prevented by dietary hesperidin or α-glucosylhesperidin. The Ca, P and Zn concentrations in 
the femur were significantly higher in the hesperidin-fed and E2 groups than in the OVX 
group. Histomorphometric analyses showed that the trabecular bone volume and trabecular 
thickness in the femoral distal metaphysis were markedly decreased (P< 0.05) by OVX, and 
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α-glucosylhesperidin significantly prevented this bone loss. Furthermore, hesperidin 
decreased the osteoclast number of the femoral metaphysis in OVX mice, as did E2. Serum 
and hepatic lipids were lower in mice that consumed the hesperidin-containing diets (P< 
0.05) than in the OVX group fed the control diet. These results suggest a possible role for 
citrus flavonoids in the prevention of lifestyle-related diseases because of their beneficial 
effects on bone and lipids. 
xi. Radioprotective Effect 
The present study was aimed to evaluate the radioprotective efficacy of hesperidin, a 
flavonone glycoside against X-ray radiation-induced cellular damage in the liver of Swiss 
albino mice. The first phase of the study was carried out to fix the effective concentration of 
hesperidin by performing a 30 days of survival studies using different graded doses [12.5, 25, 
50 and 100 mg/kg body weight] of hesperidin administered orally to mice via intragastric 
intubations for seven consecutive days prior to exposure of whole body radiation (10 Gy). 
Based on the results of survival studies, the effective dose of hesperidin was fixed which was 
then administered to animals orally via intragastric intubations for seven consecutive days 
prior to exposure of whole body radiation (4 Gy) to evaluate its radioprotective efficacy by 
performing various biochemical estimations, comet assay, DNA fragmentation assay and 
histopathological studies in the liver of Swiss albino mice. The results indicated that 
radiation-induced decrease in the levels of endogenous antioxidant enzymes and increase in 
lipid peroxidative index, DNA damage and comet parameters were altered by pre-
administration with the effective dose of hesperidin [25 mg/kg body weight] which restored 
the antioxidant status to near normal and decreased the levels of lipid peroxidative index, 
DNA damage and comet parameters. These results were further confirmed by 
histopathological examinations which indicated that pre-administration with the effective 
dose of hesperidin reduced the hepatic damage induced by radiation. Thus the current study 
shows hesperidin to be an effective radioprotector against radiation induced damage in the 
liver of mice. 
xii. Anti-Ulcer 
Hesperidin and neohesperidindihydrochalcone show a marked capacity to reduce the ulcer 
index in cold-restraint induced ulcer in a clear dose-related manner. The amount of gastric 
mucus and total protein were not modified, but there was a significant increase in hexosamine 
content. When the acute ulcer was induced by absolute ethanol HESP was inactive. These 
results suggest that mucus is not involved in the antiulcer activity. In both experimental 
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models, HESP and NEOHESP did not produce an increase in total PGE2, suggesting that this 
mechanism of action is not involved in the antiulcer activity of these compounds. 
xiii. Peripheral Organ Systems 
Liver 
Following irradiation, 50-100 mg/kg oral ingestion of hesperidin for one week after 
irradiation therapy has been noted to reduce the elevation of liver enzymes and reduce lipid 
peroxidation to near normal levels (Pradeep et al., 2008) which has been noted elsewhere 
(Pradeep et al., 2012). In rats administered the liver toxin TCDD, 50 mg/kg hesperidin daily 
alongside the TCDD, was able to attenuate the oxidative and inflammatory changes which 
were thought to underlie the protective effects on the organ (Bentli et al., 2013). Oral 
ingestion of hesperidin (25mg/kg) daily for 22 weeks in rats prevented an increase in liver 
enzymes (84-89% normalization on ALT, AST, and ALP) and also significantly attenuated 
the rise in other biomarkers of toxicity (tissue phospholipids, free fatty acids, and cholesterol) 
seen in the liver, lung, and kidneys of these rats (Balakrishnan&Menon, 2007). 
Lungs 
Hesperidin is thought to be beneficial for the lungs due to men with higher hesperidin intakes 
having lower mortality from cerebrovascular disease and lung cancer with lower incidences 
of asthma (Knekt et al., 2002) and that hesperitin possesses a selective PDE4 inhibitory 
effective in vitro (Ko et al., 2004).  
Hesperidin (30-100 µM/kg oral ingestion) two hours before and twice after an after way 
hyperresponsiveness test in mice (for airway allergies) noted a mild attenuation of symptoms 
suggesting antiallergic effects, and this was associated with less infiltration of immune cells 
(leukocytes and macrophages) into lung tissue; (Yang et al., 2012) and this has been 
replicated elsewhere with 10-30 mg/kg (but not 5mg/kg) hesperidin an hour before 
stimulation (Wei et al., 2012) Since a variant (HDME) that was a more effective PDE 
inhibitor was more effective, implicating that as a mechanism of action (Yang et al., 2012). 
Kidneys 
In rats given 100-200mg/kg hesperidin daily for a week, there are protective effects against 
subsequent injections of cisplatin with more efficacy in reducing lipid peroxidation (TBARS; 
a 95% attenuation at 100mg/kg and full normalization with a further 18% reduction at 
200mg/kg) and protein carbonyls (79-84% normalization) rather than normalizing creatinine 
(30-53%) and BUN (34-57%); these changes were associated with full preservation of SOD 
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and glutathione-S-transferase activity at both doses. In control rats, 100-200mg/kg hesperidin 
trends to reduce oxidation but it do not reach significant levels (Sahu et al., 2013). 
Testes 
 In doxorubicin induced testicular toxicity, hesperidin (25-100mg/kg) daily give times weekly 
for five weeks is able to attenuate oxidative changes induced by doxorubicin and alongside 
that also normalized signs of toxicity such as abnormal sperm cells and testicular 
histopathology (Trivedi et al., 2011) In a mouse model of androgen deficiency, 
supplementation of either hesperidin (0.5% of the diet) or G-hesperidin (0.7%) failed to 
reduce the atrophy of the testicles that occurred from the androgen deficiency (Chiba et al., 
2014).  
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3. SCOPE OF THE WORK 
The present study was aimed to evaluate the protective effect of hesperidin against LPS- 
induced Neuroinflammation and forced-swimming-stress-induced alterations in biochemical, 
behavioral, and histopathological changes in rats. 
Stress is a very crucial factor in the maintenance of health and disease ( McIlroy & Craig., 
2004). Stress induces changes in emotionalbehavior and anxiety like state, which are 
associated withoxidative damage, that is, free radical damage (Fontella et al.,2005 ; Firuzi et 
al., 2006). Acutestress triggers numerous cellular cascadesthat lead to increase in ROS 
production (liu et al., 1996). Because of thebrain high oxygen consumption, abundant lipid 
content,and relative paucity of antioxidant enzymes, the centralnervous system is highly 
vulnerable to free radical damage (Halliwell & cutteridge., 1985). Immobilization stress has 
also been reported to induce2-3-fold higher rise of plasma cortisol level; increasedcortisol 
level has been linked with anxiety-like behavior (Bristowet al.,2007; Goyal et al., 2007 ). It is 
been reported that stress triggers the motoralteration in different animal models and central 
nucleus ofamygdala is important in modulating affective response tostress ( LeDoux ., 1998). 
Natural products such as bioflavonoids possess very goodantioxidant property and inhibit 
lipid peroxidation in biological membranes (Maridonneau-Parini et al., 1986). Hesperidin is 
a such natural bioflavonoidthat possesses very good antioxidant property (Haenen et el., 
1997)and it has been proved to be very effective in various neurobehavioral diseases .Stress 
has been known to cause serious disturbances in behavior and cognition.  
With this background, the present study was designed toinvestigate the possible 
neuroprotective effect of hesperidin against acute immobilization-stress-induced anxiety-like 
behavior and associated oxidative damage in mice.  
Neuroinflammation induced by LPS plays a major role and has a cascading effect on the 
functioning of the brain. There are, indeed, a multitude of paradigms assessing various 
aspects of the neurodegeneration like behavioral assessment, biochemical analysis and 
histopathological evaluation. Till now, some of the paradigms have not been used at all in the 
evaluation of hesperidin against neurodegeneration of adult rats in endotoxemia. 
In this study, an attempt has been made to investigate whether pretreatment of animals with 
hesperidin for 30 days and then a single exposure to LPS-induced endotoxemia and 
immobilization stress would protect the animals from the corresponding effect on functions 
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of brain, using a series of behavioral tests, in vivo brain antioxidant defense elements and 
histological studies.  
Animals were subjected to endotoxemic (stress) and an acute stress (forced swimming cold 
stress, a model for physical stress). We anticipate that the battery of tests used in the presence 
study, could contribute to the evaluation of hesperidin against neurodegeneration induced 
endotoxemia and acute stress and may shed an insight into the mechanism of action. Hence, a 
spatial attention is focused to understand the treatment of neurodegeneration by natural 
flavonoids, preferably hesperidin. 
Therefore, to evaluate the traditional and modern claims of hesperidin, we have attempted to 
investigate the effect of LPS-induced endotoxemic stress+ acute stress on several aspects of 
brain metabolism including the measurement of brain malondialdehyde (MDA), reduced 
glutathione (GSH) contents, catalase (CAT) and superoxide dismutase (SOD) activities, as 
indices of oxidative stress; brain cholesterol and phospholipids that reflect membrane 
integrity and synthetic capacity. 
In addition to these, behavioral studies such as locomotor activity, elevated plus maze, open-
field test and forced swim test andhistopathological analysis of rat brain were studied. 
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4. Plan of Work 
The present study is designed to assess the protective effect of marketed product of hesperidin in 
LPS- and stress-induced neurodegenerative rat model. The work has been planned to be carried 
out in the following phases as outlined below: 
Phase: 1 
I.a. Procurement of hesperidin 
 Hesperidin will be procured from sigma Aldrich ltd., Bangalore, India. 
Phase: 2 
II.a. Pharmacological studies 
b. Animals 
Healthy inbred male Sprague-Dawley rats weighing between 125-150g received from the central 
animal house of the institute and will be used for the study. The institutional animal ethical 
committee under the regulation of CPCSEA guidelines, New Delhi, has approved the protocol 
for the animal study. 
c. Induction of stress 
i. Endotoxemic stress: 
LPS will be used to induce endotoxemia-induced neurodegenerative / oxidative stress in rats 
and the effect of Hesperidin on the behavioral and biochemical parameters along with 
histopathological analysis will be studied. 
 
ii. Cold Physical stress:  
Forced swimming induced stress model will be employed to induce immobilization stress 
induced anxiety in rats. 
 
d. Experimental Protocol: 
The rats were divided into nine groups of 6 animals each. The treatment period comprised of 30 
days in four groups, and stress period for chronic unpredictable stress (CUS) was 10 days and for 
acute stress was 2 h. They were grouped under the following regimen: 
Group-I, served as control and it received 0.9% normal saline. 
Group-II, received LPS + acute stress. 
Group-III, received diazepam (2mg/kg) + LPS + acute stress. 
Group-IV, pretreated with Hesperidin (50mg/kg) + LPS + acute stress. 
Group-V, pretreated with Hesperidin (100mg/kg) + LPS + acute stress. 
Group-VI, pretreated with Hesperidin (200mg/kg) + LPS + acute stress. 
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Drug treatment 
Groups Drugs Drug treatment Routes Dose 
1 Control(saline) 30 days p.o., - 
2 LPS + acute stress 30 days i.p., + cold stress 1.5 mg/kg 
3 Diazepam + LPS + acute stress 30 days p.o., 2mg/kg 
4 Hesperidin-I 30 days p.o., 50mg/kg 
5 Hesperidin-II 30 days p.o., 100mg/kg 
6 Hesperidin-III 30 days p.o., 200mg/kg 
 
d. Evaluation of general behavioral alterations in Stress induced rats:  
i. General behavioral parameters   
 Body weight 
 Food intake 
 Water intake 
ii. Behavioral studies 
i) Test for anxiety studies 
 Ambulatory behavior test 
 Elevated plus maze 
 Open field test 
Phase: 3 
III.a. Biochemical Analysis 
i. Specimen Preparation 
At the end of the behavioral studies, the animals were anesthetized with either and sacrificed by 
cervical dislocation, the brains quickly removed, weighed, rinsed in ice-cold isotonic saline and 
one half of the brain was processed as follows:  
One half of the brain tissue homogenate was prepared with ice cold Tris-KCl buffer (0.05M Tris 
and 1.15% KCl, pH 7.4), using Elvehjem hand homogenizer, fitted with Teflon pestle. The 
homogenate was centrifuged at 2000 rpm at 4°C for 15 minutes, and the supernatant was used for 
the biochemical analysis. 
The other half of the brain was stored in FAM (40% formaldehyde, acetic acid and methanol in the 
ration of 1:1:8), and used for histopathological analysis. 
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III. b. In-vivo Studies 
Enzymatic and non-enzymatic antioxidants play a crucial role in neurodegeneration. Hence, 
the effects of hesperidin and the following antioxidant defense elements in brain were also be 
measured:  
i. Superoxide dismutase (SOD) 
ii. Catalase (CAT) 
iii. Total glutathione (GSH) 
iv. Malondialdehyde (MDA) 
v. Brain phospholipids (BPL) 
vi. Brain cholesterol (BCh) 
 
Phase: 4 
IV.a. Histopathological Examinations 
The other half of the brain will be extracted and embedded in paraffin and saggital section of 5 µm 
thickness of brain and the extent of anatomical damage in the appropriate was analyzed using 
hematoxylin/eosin. The stained sections of brain tissues will then assessed for the extent of 
protective actions of drugs. 
Phase: 5 
5.a. Statistical Analysis 
The data will be expressed as mean ± SEM from six observations in each group. The values were 
analyzed by one-way analysis of variance (ANOVA), followed by Dunnet’s multiple comparison 
posttests.  
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5. Materials and Methods 
 
4.a. Chemicals Used 
Ferrous chloride, ferric chloride, thiobarbituric acid (TBA), calf thymus DNA, 
trichloroacetic acid (TCA), phenazinemethosulphate, potassium ferricyanide, were 
purchased from Sigma Aldrich Co., St Louis, USA. Reduced nicotinamide adenine 
dinucleotide phosphate (NADPH), reduced glutathione (GSH), 5, 5-dithiobis-2-
nitrobenzoic acid (DTNB), and 1-chloro-2,4-dinitrobenzene (CDNB) were obtained 
from Sisco Research Laboratories Pvt Ltd., Mumbai, India. Ascorbic acid, 
nitrobluetetrazolium (NBT) and butylatedhydroxyanisole (BHA), methanol, ammonium 
acetate and formic acid (AR grade) were obtained from S.D. Fine Chem Ltd., Biosar, 
India. Ammonium thiocyanate was purchased from E Merck Ltd., Mumbai, India. 
Lyophilized lipopolysaccharide powder from Escherichia Coli, serotype 055:B5 
(containing ≥ 10,000 endotoxin units / mg LPS) and potassium dihydrogenortho 
phosphate (AR grade) were purchased from Sigma Chemical Company, New Delhi, 
India. 
4.b. Induction of LPS endotoxemia 
Endotoxemia-mediated neurodegeneration can be elicited by systemic injection of LPS, 
triggering neuronal death with increased release of glutamate and NO production. 
Furthermore endotoxemic shock involves increase in free radicals, lipid peroxidation, 
decreased mitochondrial function and cytokine release. Endotoxin and cytokines have 
been reported to drive a cascade of mediators, which result in degeneration. Number of 
therapeutic agents modifying the above mentioned parameters may be tried in order to 
improve the outcome of endotoxemic injury. 
The dose of LPS required to produce optimal endotoxemia, with relevance to our 
study, is standardized by testing different doses of LPS (10, 5, 2.5 mg/kg) in rats until 
a desired endotoxemic response was observed. LPS toxicity was induced in non-fasted 
male SD rats, weighing between 125-150 g, by single intraperitoneal injection of 
1.5mg/kg of LPS in saline 1 hour after LPS administration. Hesperidin was 
administered at the dose levels of 50, 100 and 200 mg/kg body weight, up to 30 days 
and the effect was compared with diazepam (2mg/kg). 
4.c. Drug Treatment  
The following drugs were administered to the rats as per the schedule given below: 
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Groups Drugs Drug Treatment Routes Dose 
1. Control 30 days p.o., - 
2. Diazepam 30 days p.o., 2mg/kg 
3. LPS + acute stress 31st day i.p., 1.5 mg/kg 
4. Hesperidin-I 30 days p.o., 50 mg/kg 
5. Hesperidin-II 30 days p.o., 100 mg/kg 
6. Hesperidin-III 30 days p.o., 200 mg/kg 
 
The animals were pretreated with hesperidin and standard drugs for 30 days. On the 
last day (31stday), the animals were administered with an intraperitoneal injection of 
LPS, and thereafter the animals were subjected to the experimental protocol, as 
mentioned in the plan of work. 
4.d. Evaluation of behavioral alteration in LPS-treated rats 
The animals in this model were subjected to the same behavioral procedure 
immediately following treatment with hesperidin and standard drugs, 1 hour after 
intraperitoneal administration of LPS. The rats were observed for the behavioral 
changes during the entire treatment period.   
4.e. Pharmacological Evaluation 
4.e.1.General behavior 
The psychological andphysiological effects of immune activation following LPS 
injection resemble the characteristics of depression. The essential features of 
depression are depressed mood and loss of interest or pleasure in all, or almost all 
activities (anhedonia). 
i. Evaluation of general behavioral alterations in Stress induced rats: 
The animals were subjected to the following behavioral procedures initially and after 
induction of stressors. During the entire period of study the animals were observed for 
any changes in behavior and suitably noted. 
4.e.2.Test for Anxiety Studies 
i.Actophotometer 
The actimeter test was performed independently as a test to record the effects of the 
drugs on the spontaneous locomotor activity of rats using a photo-electric actimeter, 
1h after administration of drug.The apparatus consist of stainless steel box containing 
transparent cages (270x20x110cm) in which the animal’s horizontal activity in 
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measured by two light beams connected to a photoelectric cell. The total number of 
beam crossings will be recorded over a period of 5 min (Ramanathan et al., 2007).  
ii. Elevated Plus Maze 
The elevated plus maze (EPM) was performed on rats as a standard test of fear and 
anxiety, where anxiety-related behavior is measured by the degree to which the rodent 
avoids elevated, enclosed arms of the maze and exhibits defense behaviors such as head 
dips and scanning posture. The maze was elevated 50 cm above ground and consisted of 
four arms 48cm in length. Two opposing arms were open with no walls, while 48cm 
high walls enclosed the other two opposing arms. There was a 10x10cm open area at the 
confluence of the four arms. Testing procedures followed the behavioral neuroscience 
protocol for EPM (Current Protocols in Neuroscience 2001, John Wiley and Sons: 
Supplement 10 section 8.3.6.Basic Protocol 4). 
One hour before animals were put in the maze, they were placed in a darkened holding 
room followed by testing in a dimly lit room. Animals were placed individually in the 
center facing an open arm, and the rodent’s behavior recorded by video camera. Tapes 
were scored by a researcher blind to treatment for (1) first arm preference, (2) entries 
into closed arms and (3) entries into open arms.  
iii. Open field test 
An open field apparatus similar to that of Bronstein (1972), made of plywood and 
consists of a square (61×61×61cm) was used. The entire apparatus is painted black 
except for 6mm white lines that divided the floor into 16 squares. The open field was 
lighted by a 100W bulb focusing onto the field from a height of about 100cm from the 
floor. The entire room was kept dark during the experiment. Each animal was 
centrally placed in the test apparatus for 5 min and the behavioral aspects of anxiety 
such as ambulation, rearing, self-grooming, defecation and activity in central squares 
were recorded. The open-field apparatus was then cleaned using 5% ethanol before 
introducing the next animal, to preclude the possible cueing effects of odors left by 
precious subjects. To minimize the possible influences of circadian changes on rat 
open-field behavior, control and experimental animals were intermixed.  
Forced swimming induced stress: 
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In order to produce swimming induced stress, rats were made to swim in a cylinder 
(30cm diameter and filled to a height of 20 cm with 15 cm of space above the head of 
the rat) for 30 min. session in a day for ten consecutive days (Ferry et al., 1991). 
EXPERIMENTAL PROTOCOL 
The rats were divided into nine groups of 6 animals each. The treatment period 
comprised of 30 days in four groups, and stress period for chronic unpredictable stress 
(CUS) was 10 days and for acute stress was 2 h. They were grouped under the 
following regimen: 
Group-I,served as control and it received 0.9% normal saline. 
Group-II,received LPS + acute stress. 
Group-III,received diazepam (2mg/kg) + LPS + acute stress. 
Group-IV, pretreated with Hesperidin (50mg/kg) + LPS + acute stress. 
Group-V, pretreated with Hesperidin (100mg/kg) + LPS + acute stress. 
Group-VI, pretreated with Hesperidin (200mg/kg) + LPS + acute stress. 
 
4.6 Biochemical Analysis 
4.6.1 Specimen Preparation 
At the end of the behavioral studies, the animals were anesthetized with either and 
sacrificed by cervical dislocation, the brains quickly removed, weighed, rinsed in ice-
cold isotonic saline and one half of the brain was processed as follows:  
One half of the brain tissue homogenate was prepared with ice cold Tris-KCl buffer 
(0.05M Tris and 1.15% KCl, pH 7.4), using Elvehjem hand homogenizer, fitted with 
Teflon pestle. The homogenate was centrifuged at 2000 rpm at 4°C for 15 minutes, 
and the supernatant was used for the biochemical analysis. 
The other half of the brain was stored in FAM (40% formaldehyde, acetic acid and 
methanol in the ration of 1:1:8), and used for histopathological analysis. 
4.6.2 In-vivo Studies 
a. Superoxide dismutase (SOD)  
The activity of SOD was estimated following the method of (Kakker et al., (1984). 
The measurement of SODinvolves the inhibition of the formation of the blue colored 
formozan dye from nitro blue tetrazolium (NBT), in the presence of 
phenazinemethosulphate (PMS) and reduced nicotinamide adenine dinucleotide 
(NADH). The incubation mixture consisted of sodium pyrophosphate buffer (pH 8.3; 
0.052 M; 1.2ml), PMS (186 µM), NBT (300 µM) and NADH (780 µM; 0.2ml). The 
reaction was initiated by the addition of NADH; followed by incubation for 90 sec at 
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37°C. The reaction was terminated by the addition of glacial acetic acid (1ml), n-
butanol (4ml), shaken vigorously, centrifuged at 4000rpm for 1min and the upper 
butanol layer was read at 560nm, against butanol blank. 
 
b. Catalase (CAT) 
The activity of CAT was measured according to the method of Beers &Sizer (1952). 
CAT measurement was done based on the ability of CAT to inhibit oxidation of 
hydrogen peroxide (H2O2). 2.25ml of potassium phosphate buffer (65 mM, pH 7.8) 
and 100µl of the brain homogenate or sucrose (0.32 M) were incubated at 25°C for 30 
minutes. H2O2 (7.5 mM; 650µl) was added to initiate the reaction. The change in 
absorption at 240 nm was measured for 2-3min. dy/dx for every minute for each assay 
was calculated and the results are expressed as CAT units of protein.   
CAT (U) in 100µl of sample = dy/dx X 0.0003 / 38.3956 X 10-6 
c. Total glutathione (GSH)  
The following working solutions was prepared from the stock buffer for the 
estimation of GSH as follows: (1) 125mM sodium phosphate, 6.3mM sodium EDTA, 
adjusted to pH 7.5; (2) 0.3mM NADPH, 6mMdinitrothiobisnitroso benzoic acid 
(DTNB) and (3) approximately 50 units of glutathione reductase per ml and stored at 
4°C. During the assay, 700µl of NADPH, 100µl of DTNB, 25µl of glutathione 
sample, 10µl of glutathione reductase were incubated at 30°C and 165µl of deionized 
water were incubated at 30°C and the absorbance was read immediately at 420nm 
(Anderson, 1985). 
d. Lipid peroxide (TBARS) 
Ohkawa et al., (1979)methodwas used to estimate the total amount of lipid 
peroxidation (LPO) product. LPO was estimated in terms of TBARS and 
malondialdehyde (MDA) was taken to represent the TBARS. The incubation mixture 
consisting of 0.5ml of supernatant brain homogenate, 0.2ml of 8% sodium dodecyl 
sulphate, 1.5ml of 20% acetic acid solution (adjusted to pH 3.5 with 1NaOH / 0.1N 
HCl) and 1.5ml of 0.9%. 
Aqueous solution of thiobarbituric acid (adjusted to pH 7.4 with 1N NaOH / 0.1N 
HCl) was made up to 5.0ml with double distilled water and then heated in boiling 
water bath for 30 minutes. After cooling, the redchromogen was extracted into 5ml of 
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the mixture of n-butanol and pyridine (15.1v/v) centrifuged at 4000 rpm for 10 
minutes. The absorbance of organic layer was measured at 532 nm. 1, 2, 3, 3-
tetraethoxypropane (TEP) was used as an external standard and the levels of lipid 
peroxide was expressed as µmoles of MDA / g protein. The calibration curve of TEP 
was prepared by the above procedure taking 80-240nmoles of TEP as standard over 
which, linearity was obtained.  
e.Brain phospholipids (BP) 
 Brain lipids were extracted (Bligh & Dyer, 1959) and used for estimation of cholesterol 
(kit by bio Merieux, France) (Allain et al., 1974), and phospholipids (Raheja et al., 
1973; Vaskovsky&Kostetsky, 1968).  
f. Estimation of Lipids 
 For quantitative lipid extraction the lipid withheld in the tissue residue is recovered by 
blending the residue and filter paper with 100 ml chloroform. The mixture is filtered 
through the original Buchner funnel and the blender jar and residue are rinsed with a 
total of 50 ml chloroform. This filtrate is mixed with the original filtrate prior to 
removal of the alcoholic layer. A portion of the lipid extract containing 100-200 mg 
lipid is evaporated to dryness in a tared flask and the weight of the lipid residue 
determined. Evaporation, facilitated by a stream of nitrogen, is carried out in a water 
bath at 40-50" C and the residue is dried over phosphoric anhydride in a vacuum 
desiccator. After weighing, a small volume of chloroforrn is added to each flask to 
detect the presence of non-lipid material (insoluble). If non-lipids are present, the 
chloroform is carefully decanted and the flask rinsed three times with chloroform. The 
dry weight of the residue is determined and subtracted from the initial weight. The lipid 
content of the sample is calculated as follows (Bligh & Dyer, 1959): 
Total lipid = weight of lipid in aliquot X volume of chloroform layer / volume of 
aliquot. 
g.Estimation of Brain Cholesterol  
Cholesterol esters are hydrolyzed to free cholesterol by cholesterol ester hydrolase 
(EC 3.1.1.13). The free cholesterol produced is oxidized by cholesterol oxidase to 
cholest-4-en-3-one with the simultaneous production of hydrogen peroxide, which 
oxidatively couples with 4-aminoantipyrine and phenol in the presence of peroxidase 
to yield a chromogen with maximum absorption at 500 nm. Optimization studies were 
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performed for each of the components of the cholesterol assay. A native human serum 
pool with a total cholesterol content of 500 mg/dl was used in the optimization of 
cholesterol ester hydrolase, sodium cholate, and pH; a 600 mg/dl cholesterol standard 
in isopropanol was used in the remaining optimization studies. When we had 
ascertained the optimum concentration of a particular ingredient it was maintained at 
that concentration while the next ingredient was optimized. In the manual assay of 
total cholesterol by the present method, 30 µL of serum is incubated with 3.0ml of 
reagent for 10 mm at 37 °C and the absorbance at 500 nm is measured vs. a reagent 
blank. Concentrations of unknown samples are determined from a standard curve 
constructed by using cholesterol standards in isopropanol (Allain et al., 1974). 
h. Estimation of Phospholipids  
The phospholipids are estimated using a modification of the spray reagent described 
by Vaskovsky & Kostetsky (1968) after separation by thin-layer chromatography and 
elution from the silica gel, are heated with a chromogenic solution that is a 
modification of a spray reagent formulated by Vaskovsky & Kostetsky(1968). The 
absorbance of the colored complex was read at 710 nm, and it followed Beer’s law in 
the range of 1-10 microgram of phospholipid phosphorus (Raheja et al., 1973). 
4.8 Histopathological Examinations 
At the end of the behavioral procedures, the rats were scarified as described above. 
The brain of all the animals are extracted and embedded in paraffin. A sagital section 
of 5µm thickness of was carefully prepared using microtome and the tissues were 
stained using hematoxylin/eosin. The stained sections of brain tissues were then 
assessed for the extent of protective actions of drugs. 
4.9 Statistical Analysis 
The data are expressed as mean ± SEM from six observations in each group. The 
general behavioral data was subjected to one-way analysis of variance (ANOVA), 
followed by Dunnet’s multiple comparison posttests. A probability level (p) of value 
of less than 0.05 was considered to be statistically significant. The statistical analysis 
was carried out using GraphPad Prism version 4.03 for Windows (GraphPad Prism 
Software, San Diego, California, USA).    
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6. RESULTS 
5.1. Effect of Hesperidin and Diazepam on behavior Studies in LPS-Treated 
Rats 
5.1.1. General Behavior 
 After induction of endotoxemia, the animals were observed for general behavior 
up to 1 hour. Endotoxemia may result in psychological and physiological changes in 
behavior, attributable to neurodegeneration. The animals were observed for a period 
of 45 minutes following administration of LPS after pretreated with hesperidin and 
diazepam for the changes in general behavior. Rats treated with LPS exhibited a 
prolonged suppressive behavior in comparison to the control rats. Pretreatment with 
hesperidin for 30 days, resulted in profound calmness. 
5.2. Anti-anxiety Studies 
a. Effect of Hesperidin and Diazepam on Locomotor Activity in LPS-Treated 
Rats Using Actophotometer 
Locomotor activity of LPS-treated animals was determined with an 
actophotometer and the results are shown in figure 1 and table 1. When tested on an 
actophotometer, a significant decrease in movement levels was seen in LPS-treated 
rats (86.33±6.15), when compared with control animals (211±29.15). A significant 
improvement in movement activity was seen in LPS-treated animals administered 
with hesperidin at different doses (50 mg/kg: 219.3±25.57; 100 mg/kg: 203±13.5; 200 
mg/kg:165.1±11.37).The locomotor activity of rats treated with Diazepam 
(177±14.66) was found to be significantly better. 
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Table1. Effect of Hesperidin and Diazepam on LPS Treated Rats by Locomotor 
Activity 
Groups Number of Movement (in 5 min) 
Control                     211±29.15 
LPS + Stress 86.33±6.159 
Hesperidin 50 mg/kg 219.3±25.57 
Hesperidin 100 mg/kg                     203.0±13.5 
Hesperidin 200 mg/kg 165.1±11.37 
Diazepam                     177.0±14.66 
 
 
 
Fig 1: Effect of Hesperidin and Diazepam on Locomotor activity
in LPS-Treated Rats by Actophotometer
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    (Values are mean SEM observation from six animals from each group )
                  (*p<0.005; **p<0.01; ***p<0.001; ****p<0.0001)
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b. Effect of Hesperidin and Diazepam on Elevated Plus Maze Behaviour in 
LPS-Treated Rats 
Anxiety levels were determined with a plus-maze apparatus and the results are 
shown in figure 2 and table 2. When tested on an elevated plus-maze, a significant 
increase in anxiety levels (time spent in open arms [OP]: 2.16±0.40; time spent in 
closed arms [CL]:163.84±1.55) were seen with LPS-treated rats on Day 30, when 
compared with control animals (OP: 12.5± 3.54; CL: 153.6.0±8.34). A significant 
reduction in anxiety levels were observed with hesperidin treated rats at different 
doses (50 mg/kg: OP: 6.0±2.22 & CL: 167.1±3.88; 100 mg/kg: OP: 19.16±0.87 & 
CL: 144.16±5.52; 200 mg/kg: OP: 16.0±1.39 & CL: 149.3±1.68). The behavioral 
effect of Diazepam was also found to produce significant antianxiety effect (OP: 
7.83± 2.12 & CL: 148±6.33). 
Table2. Effect of Hesperidin and Diazepam on LPS-Treated by Rats Elevated 
plus Maze Behavior 
Groups 
Time Spent In  Arms (In Sec) 
Open (OP) Entry Closed (CL) Entry 
Control 12.5± 3.54   153.6.0±8.34 
LPS + Stress 2.16±0.40         163.84±1.55 
Hesperidin 50mg/kg         6.0± 2.03  167.1±3.88 
Hesperidin 100mg/kg 9.16± 0.87  144.16±5.52 
Hesperidin 200mg/kg 16.0±1.39  149.3±1.68 
Diazepam  7.83± 2.12  148±6.33 
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c. Effect of Hesperidin and Diazepam in LPS-Treated Rats in Forced Swim 
Test 
Antidepressant activity of LPS-treated animals was determined by forced swim 
test and the results are shown in figure 3 and table 3. When tested by forced swim 
test, a significant decrease in movement level was seen in LPS-treated rats 
(4.58±1.08), when compared with control animals (11±1.77). A significant increase in 
movement activity was seen in hesperidin-treated animals at different doses 
(50mg/kg: 12.16±1.68; 100 mg/kg 9.83±0.30; 200mg/kg: 7.83±1.07). Diazepam 
(9±0.96) was also found to have significant antidepressant activity. 
Table3. Result of effect of Hesperidin and Diazepam in LPS-Treated rats by 
Forced Swim Test  
Groups Immobility Time (in sec) 
Control 11±1.77 
LPS 4.58±1.08 
Hesperidin 50 12.16±1.68 
Hesperidin 100 9.83±0.30 
Hesperidin 200 7.83±1.07 
Diazapam 9.0±0.96 
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5.3. Effect of Hesperidin and Diazepam on Rat Brain Antioxidant System in 
LPS-Treated Rats 
5.3.1. Effect of Hesperidin on Superoxide Dismutase (SOD) Levels in LPS-
Treated Rat Brain 
 The SOD profile in the rat brain is depicted in table 4 and figure 4. In comparison 
to control rats (37.28±1.30), LPS insult resulted in significant reduction of SOD level 
in brain (75.81±2.79). Pre-treatment with hesperidin at different doses (50 mg/kg: 
51.98±0.99; 100 mg/kg: 40.28±0.32; 200mg/kg: 36.87±0.29) for 30 days significantly 
improve the SOD activity in comparison to LPS-treated groups in the brain studied. 
Among all the groups, a marked increase in SOD status was observed with 50 mg/kg 
of hesperidin. 
5.3.2. Effect of Hesperidin on Catalase (CAT) Levels in LPS-Treated Rat Brain 
 Table 4 and figure 4 showed the alteration of CAT levels in brain studied. In 
comparison to control rats (16.95±0.26), LPS induction resulted in significant 
reduction of CAT level of brain (2.67±0.39). Pre-treatment with hesperidin at 
different doses (50 mg/kg: 10.11±0.29; 100 mg/kg: 12.63±0.27; and 200mg/kg: 
14.27±0.27) for 30 days significantly improved the CAT activity in comparison to 
LPS-treated groups in the brain studied. Among all the groups, a marked increase in 
CAT status was observed with LPS-treated groups administered with 200 mg/kg of 
hesperidin. 
5.3.3. Effect of Hesperidin on Reduced Glutathione (GSH) Levels in LPS-
Treated Rat Brain 
 The effect of hesperidin in LPS-treated rats on GSH levels are summarized in 
table 4 and figure 5.In comparison to control rats (2.43±0.40), LPS induction resulted 
in significant increase of GSH level of brain (1.91±0.23). Pre-treatment with 
hesperidin at different doses (50 mg/kg: 67.29±0.44; 100 mg/kg: 2±0.18; 200mg/kg: 
1.80±0.22) for 30 days significantly improved the GSH activity in comparison to 
LPS-treated groups in the brain. Among all groups, a marked increase in GSH status 
was observed in LPS-treated groups administered with 50 mg/kg of hesperidin. 
5.3.4 Effect of Hesperidin on Malondialdehyde Levels in LPS-Treated Rat Brain 
 The effect of hesperidin in LPS-treated rats on MDA levels are summarized in 
table 4 and figure 5.In comparison to control rats (51.39±1.01), LPS induction  
resulted in significant increase in MDA level of brain (77.28±0.78). Pre-treatment 
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with hesperidin at different doses (50 mg/kg: 67.29±0.44; 100 mg/kg: 59.87±0.45; 
200 mg/kg: 48.32±0.47) for 30 days significantly improve the MDA activity in 
comparison to LPS-treated groups in the brain. Among all groups, a marked increase 
in MDA status was observed in LPS-treated groups administered with 50 mg/kg of 
hesperidin. 
 
 
 
 
 
 
 
Table4.Effect of Hesperidin on Antioxidant System in LPS-Treated Rat Brain 
Groups 
U of SOD/mg 
protein  
 
µmol of catalase/mg 
protein  
 
nmol GSH/mg 
protein  
 
µmol of MDA/mg 
protein  
 
Control 137.28±1.30 16.95±0.26 2.43±0.40 51.39±1.01 
LPS + Stress 75.81±2.79 2.67±0.39 1.91±0.23 77.28±0.78 
Hesperidin 50 
mg/kg 
51.98±0.99 10.11±0.29 1.67±0.19 67.29±0.44 
Hesperidin 100 
mg/kg 
40.28±0.32 12.63±0.27 2.0±0.18 59.87±0.45 
Hesperidin 200 
mg/kg 
36.87±0.29 14.27±0.27 1.80±0.22 48.32±0.47 
Diazapam 32.33±0.57 18.29±0.29 1.64±0.01 47.99±0.44 
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5.3.5. Effect of Hesperidin on Brain Phospholipid Levels in LPS-Treated Rats 
 The effect of hesperidin in LPS-treated rats on brain phospholipids levels are 
summarized in table 5 and figure 6. In comparison to control rats (69.51±0.56), LPS 
stress resulted in significant decrease of phospholipids level of brain (34±0.41). Pre-
treatment with hesperidin at different doses (50 mg/kg: 42.97±0.27; 100 mg/kg: 
56.15±0.39; 200 mg/kg: 61.74±0.28) for 30 days significantly improved the 
phospholipid level in comparison to LPS-treated groups in the brain. Among all 
groups, a marked increase in phospholipid level was observed in LPS-treated groups 
administered with 200 mg/kg of hesperidin. 
5.3.6. Effect of Hesperidin on Brain Cholesterol Levels in LPS-Treated Rats 
 The effect of hesperidin in LPS-treated rats on brain cholesterol levels are 
summarized in table 5 and figure 6. In comparison to control rats (22.05±0.27), LPS 
stress resulted in significant decrease of cholesterol level of brain (14.22±0.30). Pre-
treatment with hesperidin at different doses (50 mg/kg: 18.10±0.28; 100 mg/kg: 
18.95±0.29; 200 mg/kg: 19.27±0.35) for 30 days significantly improve the cholesterol 
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level in comparison to LPS-treated groups in the brain. Among all groups, a marked 
increase in cholesterol level was observed in LPS-treated groups administered with 
200 mg/kg of hesperidin. 
Table5. Summary of Effect of Hesperidin on Brain Phospholipid and 
Cholesterol Levels in LPS-Treated Rats 
Groups Brain phospholipids mg/kg Brain cholesterol mg/g 
Control 69.51±0.56 22.05±0.27 
LPS + Stress               34.0±0.41 14.22±0.30 
Hesperidin 50 mg/kg 42.97±0.27 18.10±0.28 
Hesperidin 100 mg/kg 56.15±0.39 18.95±0.29 
Hesperidin 200 mg/kg 61.74±0.28 19.27±0.35 
Diazepam 68.38±0.35 20.86±0.42 
 
  
Chapter 6                                                                                                    Results 
 
Dept. of Pharmacology     70       J.K.K.Nattraja College of Pharmacy 
 
 
 
 
 
Chapter 6                                                                                                    Results 
 
Dept. of Pharmacology     71       J.K.K.Nattraja College of Pharmacy 
 
5.4.1. Histological changes in LPS + Stress Treated Rat Brain  
The histological changes of brain sections of rats treated with LPS and stress, 
hesperidin and diazepam are shown in images 1-12.   
Normal cerebral brain parenchyma (image 1) and normal cerebral molecular 
layer (image 2) are seen in the brain sections of control rats. But, acute neuronal 
injury (image 3) and neuronal swelling (image 4) are seen in LPS+stress treated rats.  
In rats treated with hesperidin (50 mg/kg), section from brain showed normal 
brain parenchyma (image 5) and focal acute neuronal injury (image 6). 
In rats treated with hesperidin (100 mg/kg), section frombrain showed no 
perivascular lymphocytic infiltration/microcystic formations in glial cells (image 7) 
and mild astrocytes hypertrophy (image 8). 
No pathological brain parenchyma (image 9) and normal molecular layer 
(image 10) are shown in brain sections of rats treated with hesperidin (200 mg/kg). 
Brain sections of rats treated with diazepam showed normal brain parenchyma 
(image 11) and acute neuronal injury (image 12). 
The result showed that the endotoxin LPS-caused brain damage, are prevented 
by hesperidin at higher doses (100 mg/kg and 200 mg/kg). Hesperidin at lower doses 
(50 mg/kg) is found to be less effective. 
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Image1. Haematoxylin eosin-stained brain sections of control rats (Normal 
brain parenchyma, 10x) 
 
 
 
 
Image2. Haematoxylin eosin-stained brain sections of control rats, 40x) 
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Image3.  Haematoxylin eosin-stained brain sections of LPS treated rats (Acute 
neuronal injury, 10x) 
  
 
 
 
Image4. Haematoxylin eosin-stained brain sections of LPS treated rats 
(Neuronal swelling, 40x)  
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Image5. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 50 mg/kg (Normal brain parenchyma, 10x)  
 
 
 
 
Image6. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 50 mg/kg (Focal acute neuronal injury, 40x)  
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Image7. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 100 mg/kg (40x)  
 
 
 
 
Image8. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 100 mg/kg (Mild astrocytes hypertrophy, 40x) 
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Image9. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 100 mg/kg (10x)  
 
 
 
 
Image10. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 100 mg/kg (40x)  
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Image11. Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 200 mg/kg (10x)  
 
 
 
 
Image12.  Haematoxylin eosin-stained brain sections of rats pre-treated with 
hesperidin 200 mg/kg (40x) 
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7. DISCUSSION 
The present study was designed to evaluate the neuroprotective effect of 
hesperidin against oxidative stress induced by LPS endotoxemic and acute stress 
(forced swim-induced stress) in SD rats. The neuroprotective effect was assessed 
using a battery of general behavioral tests, biochemical analysis and histopathological 
examination. 
In an experiment conducted previously at this research lab, it was observed that 
hesperidin was found to protect the brain against LPS-induced endotoxemia in SD 
rats. The findings of the previous study encouraged us to study the potential protective 
effect of hesperidin against acute stress in addition to subjecting it to LPS induced 
endotoxemia.  
Endotoxemia was induced in rats using a single intraperitoneal injection of LPS 
(1.5 mg/kg body weight). Following LPS administration, the animals were subjected 
to acute stress (forced swim-induced stress).  
Neurodegeneration is always associated with perturbations in the levels of brain 
enzymatic and non-enzymatic antioxidant system in stressful conditions. Hence, the 
effects of hesperidin on the activities of superoxide dismutase (SOD), catalase (CAT), 
glutathione (GSH) and MDA and as an index of lipid per oxidation (LPO), brain 
phospholipids and cholesterol were analyzed in rat brains. 
In addition, a histopathological examination of the rat brain, stained in 
haematoxylin and eosin was performed to evaluate the neuroprotective role of 
hesperidin pre-treatment against LPS + acute stress-induced neurodegeneration in 
rats. 
Lipopolysaccharide (LPS), a glycolipid component of the cell wall of gram-
negative bacteria, plays a major role in the etiology of infection-associated 
inflammatory reactions and septic shock (Galanos & Freudenberg, 1993; Ulevitch & 
Tobias, 1995). Activation of immune system in response to either infection or LPS 
produces neurophysiological, neuroendocrine and physiological changes. Besides 
these neuroendocrine effects, LPS induced changes in the levels of biogenic amines in 
the hypothalamus are without doubt, significant contributors to the other central 
effects of LPS such as behavioral parameters, anxiety depression and cognition 
deficits. 
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6.1 On General behavioral parameters 
The findings of our experiment revealed that exposure to LPS + acute stress 
resulted in increase in body temperature of animals in all the groups. Furthermore, no 
increase in body temperature was observed in indomethacin treated group. This 
finding compliments work showing that the NSAIDs attenuated decrease in body 
weight and sickness behavior induced by LPS (De La Garza, 2004; Okamoto, 2002; 
O’Reilly et al., 1988; Valles et al., 2000; Yirmiya, 1996). 
The decrease in locomotors activity observed with LPS-treated rats can be 
correlated to similar reported findings in male LPS-treated mice (Engeland et al., 
2001). Treatment with hesperidin attenuated the depressed general behavior 
parameters, effects on body temperature, in a dose dependent manner. 
The suppression of food and water intake, body weight and body temperature 
is considered to be symptoms associated with depression and termed as ‘sickness 
behavior’. The sickness behavior is in some ways similar to depressive behavior 
following LPS treatment. 
Barnum et al., (2012), Filho et al., (2013) and Souza et al., (2013) have 
reported on the antidepressant action of hesperidin and further suggested that 
antidepressant drugs are clinically effective after chronic administration, Similarly, in 
the present study, chronic hesperidin treatment (for 30 days), may have produced 
adaptive changes in several neural systems, particularly monoaminergic systems and 
the hypothalamus-pituitary-adrenal axis (HPA axis) (Parrott et al., 1995; Lenczowski 
et al., 1997; Rivier et al., 1989; Tilders et al., 1994), causing attenuation of LPS-
induced suppression of food and water consumption and body weight gain, 
hyperthermia and general behavior parameters of the rats. These findings provide 
further support for the similarity between LPS-induced immune activation, anxiety 
and depression. (Filho et al.,2012). 
Activation of the HPA axis alters neurotransmitter, immune, and behavioral 
functions and may contribute to the development of depressive symptoms in humans  
(Lenczowski et al., 1997; Rivier et al., 1989; Tilders et al., 1994; Pariante & Miller, 
2001; Raison & Miller, 2001). In a report, De La Garza et al., (2004) showed that 
LPS administration + stress (Gadek-Michalska et al., 2005) strongly increased 
corticosterone release affecting behavioral parameters, which was significantly lower 
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in diclofenac-treated rats and, LPS induced changes in the concentrations of biogenic 
amines in the hypothalamus are without a doubt significant contributors to the other 
central effects of LPS such as anorexia, sleep and fever (Bluthé et al., 1992; Klir et 
al., 1993; Kluger, 1991; Nava et al., 1997; O’Reilly et al., 1988; Yirmiya, 1996). 
Thus hesperidin is considered to antagonize the effects of LPS on HPA axis, thereby 
normalizing the behavioral parameters observed in this study. 
Our findings on the levels of plasma corticosterone following LPS and stress 
are substantiated by the reports of Gadek-Michalska et al., 2005. Hesperidin has been 
found to prevent stress-induced increase in plasma corticosterone (Takahashi et al., 
1998), and normalize the stress-induced changes in biogenic amines like NA, Adr, 5-
HT, 5-HT (Goldie et al., 1982), turnover  in brain following. Hence, the inhibition of 
rise in plasma corticosterone and its effect of central neurotransmitter levels by 
hesperidin, in response to several stressors may be considered to be responsible for 
normal behavioral parameters observed with hesperidin-treated animals. 
PGE2 levels of brain interstitial fluid rise following peripheral injection of LPS 
+ stress (Gadek-Michalska et al., 2005). Pharmacological blockade of PGE2 synthesis 
attenuates many peripheral LPS-induced responses, such as fever (Sehic et al., 1996), 
brain c-fos expression, HPA-axis activation (Parrott et al., 1995), increased splenic 
sympathetic activity (MacNeil et al., 1997), activation of serotonergic and 
noradrenergic neurotransmission in hippocampus (Linthrost et al., 1996), and 
increased BBB permeability (de Vries et al., 1996). Increased production of PGE2 in 
brain, therefore, is critically involved in these CNS-linked responses to peripheral 
LPS on behavioral parameters. Hence, the positive behavioral effects produced by 
hesperidin may be attribute to its ability to inhibit and down regulate AA metabolites, 
PGE2 and COX activity, peripherally (Mura et al., 1998),  Another possible 
explanation of the present result is that, chronic treatment with hesperidin suppressed 
LPS-induced activation of cytokine systems, which normally mediate the behavioral 
effects of LPS. 
In summary LPS produced significant locomotor decrements and other general 
 behavior parameters more robustly. In addition, LPS caused significant changes in 
body temperature. The behavioral effects were significantly attenuated by hesperidin 
in a dose dependent manner. The changes in body weight, food and water intake and 
hyperthermia caused by LPS were all significantly restored by hesperidin. 
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Biochemical studies 
All cells in the body are exposed chronically to oxidants from both 
endogenous and exogenous sources but are also equipped with an antioxidant system. 
Reactive oxygen and nitrogen species, if unchecked, can contribute to chronic disease 
development by ox datively modifying lipids, nucleic acids and proteins (Liu et al., 
1996), Of all the organs, the brain is thought to be most vulnerable to oxidative 
damage due to high oxygen consumption, presence of high levels of PUFA and non-
degenerative nature of neurons, leading to various neurodegenerative diseases (Floyd 
& Carney, 1992), making them the primary target for different stressors that initiate 
lipid peroxidation, a self-propagating chain reaction resulting in significant tissue 
damage and disease. 
Under normal conditions, brain microglias are involved in immune 
surveillance and host defense against infectious agents. Activation of the immune 
system in response to infection produces neural, neuroendocrine, and behavioral 
effects. However, microglia readily become activated in response to injury or 
immunological challenges, as indicated by a change in morphology from a ramified 
resting state to an amoeboid appearance with an increase in the expression of major 
histocompatibility complex (MHC) molecules and complement type 3 receptor 
(Graeber et al., 1994; Kaur & Ling, 1992; Kreutzberg, 1996; Streit et al., 1988). 
Endotoxin-mediators induced activation of microglia is believed to contribute to 
neurodegenerative process through the release of proinflammatory and/or cytotoxic 
factors, including IL-1ß,IL-6, TNF-α, INF-γ, induction of NF-κB, macrophage 
inflammatory protein (MIP), NO, ROS, histamine, proteases, neuropeptides, 
quinolinic acid  and AA metabolites (Brosnan et al., 1994; Chao et al., 1992; Dickson 
et al., 1993; Espey et al., 1997; Lee et al., 1993; Matsuo et al., 1995). Among the AA 
metabolites, prostaglandin E2 (PGE2) levels of brain interstitial fluid was found to rise 
following peripheral injection of LPS (Sehic et al., 1996). Pharmacological blockade 
of PGE2 synthesis attenuates many peripheral LPS-induced responses, such as fever 
(Sehic et al., 1996), brain c-fos expression, HPA axis activation (Parrott et al., 1995), 
increased splenic sympathetic activity (Gaykema et al., 1995; MacNeilet al., 1997), 
activation of 5-HT and NA neurotransmission in hippocampus (Linthorstet al., 1996), 
and increased BBB permeability (de Vries et al., 1996).  
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Increased production of PGE2 in brain, therefore, is critically involved in the 
CNS-linked responses to peripheral LPS. There are three enzymes that are essential 
for the production of PGE2: PLA2, COX, and PGE2isomerase. COX-1 levels are 
relatively insensitive to inflammatory stimulation. COX-2, on the other hand, is 
strongly induced by inflammatory factors such as LPS (DeWitt, 1991). The induced 
expression of COX-2 in the brain is thought to play an important role in the elevation 
of central PGE2 levels in response to peripheral LPS (Breder et al., 1995; Cao et al., 
1995). Over expression of COX-2 has been found in the AD brains and a number of 
epidemiological studies have indicated that NSAIDs, inhibitors of COX, are 
beneficial for AD patients in delaying the clinical progression (Zandi & Breitner, 
2001). 
Several previous reports have demonstrated a number of antioxidant and anti-
inflammatory activity as due to its COX and LOX inhibitory potential of hesperidin 
and researchers have associated these effects to the presence of phenolic compounds 
in hesperidin (Hafida oufedjikh et al 1999). Hesperidin has also been reported to 
possess significant anti-inflammatory activity against a numbers of mediators of 
inflammation, in particular, against PGE2, leukotirenes (LT) and AA-induced paw 
edema in rats (Baroody et al., 2000) by virtue of their capacity to block both 
cyclooxygenase (Raymond et al., 1998). 
Several lines of investigations now suggest that primary action of LPS in the 
brain may be mediated by an increase in the concentrations of pro-inflammatory 
cytokines and several autacoids factors (Hopkins & Rothwell, 1995; Nava et al., 
1997).  
 It is well known that intense stress response results in the generation of ROS 
[hydrogen peroxide (H2O2), hydroxyl radical (•OH) and superoxide anion radical 
(O2•)], that cause lipid peroxidation; especially in membranes and can play an 
important role in tissue injury.  
 In this study the lipid peroxidation levels increased markedly following LPS 
treatment, which is in agreement with the findings of (Abd El-Gawad & Khalifa, 
(2001).In order to neutralize ROS, the body uses enzymatic copper-, zinc-SOD, CAT 
and selenium dependent GSHPx and non-enzymatic (reduced glutathione) 
antioxidants (Samson et al, 2007). 
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 The increase in the levels of SOD, and CAT observed following LPS exposure 
is an indicator of a relative increase in the superoxide radical production. The 
increased SOD activity is therefore an indication that the brain’s antioxidant 
machinery is activated in response to excessive generation of free radicals. Enhanced 
SOD activity catalyzes the conversion of superoxide anions to H2O2 which in turn 
could stimulate the second line of defense which includes GSHPx and CAT. These 
enzymes convert H2O2 into water and molecular oxygen, rationalizing the cause for 
the elevation of these two during the noise stress. CAT levels are also elevated in all 
the regions in acute noise exposure. This indicates that CAT and GSHPx substitute for 
each other in different brain regions.  
The significant reduction in GSH levels in LPS exposed animals may be 
justifiable as due to increased production of free radicals. Furthermore, it is also 
suggests that the ratio of reduced/oxidized glutathione in the cell is a good indicator of 
the level of oxidative stress (Abd El-Gawad & Khalifa, 2001). Therefore, the 
significant decrease in the GSH observed in this study indicates the oxidative stress in 
discrete regions of brain due to LPS exposure. The glutathione status of a cell could 
be taken as the most accurate single indicator of the health of the cell as the GSH 
depletion determines the vulnerability to oxidant attack.  Animals exposed to LPS-
stress showed depletion of GSH level in brain while treatment with hesperidin 
attenuated this depletion, possibly by reducing oxidative stress-induced generation of 
ROS. 
The enhanced production of brain TBARS observed in our study by LPS 
injection is in agreement with the in vivo study of Mustafa et al, 1994 and in vitro 
study of Sewerynek et al., (1995). Several mechanisms were postulated to explain this 
phenomenon. One depends on the enhanced release of cytokines that promote the 
formation and release of ROS and NO from microglia cells (Woodroofe et al., 1995). 
Another mechanism is based on the release of excitatory amino acids (EEAs), aspirate 
and glutamate that induce free radical formation during their physiological action 
(Moghaddam et al., 1993). These results may be interpreted through microglia 
activation associated with the production of NO and ROS in response to glutamatergic 
stimulation (Garthwaite et al., 1989). A third mechanism is related to the LPS-
induced mobilization of mitochondrial calcium, which in turn, activates the AA 
cascade that produces ROS (Richter & Kass et al., 1991). It has been found that LPS 
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stimulates the production of Ca2+-independent NOS with different time courses in 
various tissues (Grandati et al., 1997). Regardless of the source of NO, high levels of 
NO have been associated with membrane lipid peroxidation (Radi et al., 1991). The 
fall in brain GSH content following LPS injection is supported by a similar study 
(Mostafa et al, 1994). The increased oxidative stress depletes cellular stores of brain 
antioxidants such as GSH and vitamin E (Thomas, 1994). 
The over production of free radicals can be detoxified by the endogenous 
antioxidants causing their cellular stores to be depleted (Thomas, 1994). This is in 
accordance with our results as manifested by diminishing GSH content in shocked 
rats. GSH depletion has been found to dramatically increase cellular sensitivity 
toward NO, suggesting that intracellular GSH pools act to scavenge NO or NO-
derived species (Walker et al., 1995). Reduced brain GSH may also be due to reduced 
synthesis as a result of energy blockade since NO irreversibly inhibits complexes I–III 
of the mitochondrial electron-transport chain and cytochrome c-oxidase inhibiting 
cellular respiration and ATP production (Lizasoain et al., 1996). Shock was also 
associated with elevated brain GSHPx activity that acts as a crucial enzymatic defense 
mechanism against hydrogen peroxide and organic peroxides. Previous reports 
describing the response of SOD to different types of oxidative stresses were 
conflicting. Our results are in agreement with a number of reports indicating mild 
increase of no change in brain SOD levels following LPS-induced endotoxemic stress 
(Paschen et al., 1985; Heap et al., 1995). Measuring SOD activity in whole brain 
homogenate may not reflect specific localized changes in the activity of this enzyme 
since it varies significantly between different brain regions (Fishman et al., 1987). 
In this respect, it is worthy to note that a brain antioxidant system is the main 
target of ROS toxicity due to its high oxygen consumption (Skaper et al., 1999). The 
free radical mediated lipid peroxidation has been proposed to be critically involved in 
many neurological disorders and in the degenerative process associated with stress 
(Arivazhagan et al., 2001). Manoli et al., 2000, and Baek et al., 1999, concluded that 
the vulnerability to oxidative stress in the brain is region specific and is dependent 
upon local endogenous iron content and their ability to produce lipid peroxides. 
(Mandavilli & Rao et al., 1996 reported that regions like cortex, hypothalamus, 
hippocampus and striatum are more susceptible to oxidative damage when compared 
to cerebellum. In this study, we have observed that cerebellum, was also equally 
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susceptible to oxidative damage induced by LPS. This is also in agreement with 
previous conflicting report by (Abd El-Gawad & Khalifa, 2001). Increase in TBARS 
and decrease in the activity of CAT, and  GSH, observed in the rat brain following 
LPS treatment, were similar to that of earlier reports, wherein different stressors have 
been reported to induce similar changes in these parameters (Bhattacharya et al., 
2001). 
On the basis of published reports, and from our study, we can speculate that 
LPS-induced effects of indomethacin, used as a standard drug in this model, involve 
alterations of neuroendocrine, neuroimmune, and neurochemical function (Gaykema 
et al., 1995; Linthrost et al., 1996) and that NSAIDs counteract stress hormone (Dunn 
& Welch, 1991; Okamoto, 2002), pro-inflammatory cytokine release, and 
neurochemical effects (De La Garza et al., 2004) produced by endotoxin or cytokine 
exposure. The observed neuroendocrine and behavioral effects produced by NSAIDs 
may be the result of its actions as a COX-1 inhibitor. The effects produced by 
indomethacin may also result from its actions on PGE2, which is a major COX 
product at inflammatory sites. In a recent study, LPS-induced increases in PGE2 
production were significantly attenuated by diclofenac, but not by a COX-2-selective 
inhibitor (Giuliano & Warner, 2002). Future studies should address NSAID 
selectivity (a comparison of non-selective COX inhibitors vs. COX-2 inhibitors). 
Overall, these findings compliment emerging data that implicate a novel role for 
NSAIDs in the treatment of depressive-like behavior or symptoms associated with 
neuroendocrine or neuroimmune dysfunction (Linthrost et al., 1996; Anisman & 
Merali, 2002; De La Garza et al., 2004). 
In addition, phenolic flavonoids present a strong affinity for iron ions, which 
are known to catalyze many processes leading to the appearance of free radicals 
(Kaneko et al., 1994). It is well established that LPS induces protein tyrosine 
phosphorylation (Novagrodsky et al., 1994). The phosphorylation is an early event of 
the LPS-induced cytotoxicity and results in the production of inflammatory cytokines 
(Arditi et al., 1995). Therefore, LPS-induced cytotoxicity could be prevented by 
tyrosine kinase inhibitors. The antitoxic and organ protective effects of flavonoids 
(Middleton & Kandaswami, 1993) and their inhibitory activity against tyrosine 
protein and serine/threonine protein kinesis (Hagiwara et al., 1988) may provide a 
plausible explanation for the protective action of hesperidin in LPS-induced shock. 
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Oral hesperidin treatment produced significant brain protection as evidenced by 
reduced TBARS to the basal level, attenuating CAT production and restoring the 
GSH activity.  
The observation that an insignificant alteration in cholesterol and 
phospholipids levels, which usually affected membrane fluidity has to be contributed 
by analysis of ATP/ADP ratio and NA+,K+-ATPase activity. Therefore, such 
minimal changes in the levels of cholesterol and phospholipids in isolation is thus an 
insufficient indicator on the membrane fluidity in rat brains.  
In conclusion, hesperidin alleviated anxiety in locotmotor, elevated plus maze 
and forced swim tests, the studied antioxidant pretreatments were effective in 
reducing LPS-induced brain oxidative stress as evidenced by quenching of free 
radicals and elevation of the antioxidant GSH. All treatments elicited significant 
protection but hesperidin 200 mg/kg produced the best results. 
Neither LPS nor antioxidants had an impact on brain phospholipids or 
cholesterol metabolism. 
Additional studies are required to investigate the effect of LPS on the studied 
parameters in different brain regions and in sub cellular fractions. 
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8. SUMMARY AND CONCLUSION 
   In conclusion, the present study demonstrated that many of the symptoms that 
characterized some forms of depression in humans are presented in experimental 
animals following oxidative stress induced by LPS administration and then following 
it with acute stress. These symptoms included reduced social, exploratory and 
locomotor activity. Moreover, chronic treatment with hesperidin for 30 days 
attenuated or completely abolished these symptoms. These findings extend several 
other lines of evidence for the association between immune activation and depression, 
which were mentioned in the introduction. This study also provides a leading 
experimentation concerning the protective in vivo effects of hesperidin on various 
systems associated with oxidative stress in endotoxemic rat brain + acute stress and, 
that may provide excellent protection against several neurodegenerative diseases 
among other disorders associated with oxidative stress. Our data support the potential 
value of these agents for the therapy of septic shock.  
 Future studies should determine the molecular mechanisms that link LPS-
induced HPA axis activation, physical stress and behavioral changes and the means 
by which hesperidin attenuate these responses. On the basis of published reports, and 
especially, on the ability of hesperidin to act as a potent anti-inflammatory agent, 
acting through diverse pathways, we can speculate that  neuroprotective effects of 
hesperidin in LPS + acute stress-induced effects may be mediated  by following 
distinct mechanisms: (1) inhibition of arachidonic acid metabolic pathways, PGE2 and 
down regulation of COX and LOX (2) ability to enhance enzymatic and  non-
enzymatic antioxidant status (3) ability to act as scavengers of HESPERIDIN, (4) 
ability to attenuate the LPS-induced activation of HPA-axis (5) ability to normalize 
the levels of biogenic and acetylcholine neurotransmitter systems in brain (6) inhibit 
NO production (7) may counter the LPS-induced alterations of neuroendocrine, 
neuroimmune and neurochemical functions and stress hormonal levels. 
The current report offers compelling, but perhaps not conclusive, arguments 
for an association between behavioral and brain anatomical changes induced by LPS 
and acute stress and its attenuation by hesperidin. 
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